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INTRODUCTION
  
INTRODUCTON: 
 
 
Since time immemorial, Siddha systems of medicine have used Herbo-mineral 
preparations (thathu) for treatment of various chronic ailments. The term „Thathu‟ in 
siddha system of medicine includes Metals (ulogam), Salts of mercury (Panjasootham), 
Padanam, Salts(Kaarasaaram), Nine gem stones(Navamani) and Uparasas.  Preparation of 
thathu drugs involve extensive purification and repeated incinerations at specified 
temperatures to make the minerals ready for human consumption. According to siddha 
literature, a purified mineral does not react adversely with tissues of the body and, hence, 
a herbo-mineral drug is considered to be more powerful than almost any other medicinal 
preparation. However, the role of toxic minerals in biological systems still remains 
shrouded in controversy. Absence of significant toxicology data is a major lacuna in toxic 
mineral research despite being used since ancient times. Although scattered reports on the 
toxicity of these preparations are available in literature, their mechanism of action has not 
been conclusively established. Long-term pharmacotherapeutic and in-depth toxicity 
studies are needed to address the apprehensions raised by these herbo-mineral 
preparations. This research work aims at evaluating the toxicological aspect the thurusu 
(copper sulphate) parpam, which has been referred in siddha literature for its usage in 
treatment of various chronic disorders such as respiratory and gastro-intestinal disorders. 
Medical use of copper is found in very ancient Egyptian literatures such as Smith 
Papyrus (written between 2600 and 2200 B.C) and Ebers Papyrus (written around 1500 
B.C), in which Copper compounds were recommended for headaches, "trembling of the 
limbs" (perhaps referring to epilepsy), burn wounds, itching and certain growths in the 
neck, some of which were probably boils. Blue vitriol (copper sulfate) were used, among 
other things, in remedies for eye ailments such as bloodshot eyes, inflamed or "bleary" 
eyes, "fat in the eyes", and cataracts. 
In Greek literature copper is recommended for the treatment of leg ulcers 
associated with varicose veins. To prevent infection of fresh wounds, the Greeks 
sprinkled a dry powder composed of copper oxide and copper sulfate on the wound. 
Another antiseptic wound treatment at the time was a boiled mixture of honey and red 
copper oxide. 
  
Copper and its derivatives had been firmly established as an important drug in 
Roman physician Cornelius Celsu‟s pharmacopoeia for treatment of venereal diseases 
and non-healing chronic ulcers. 
Copper was also employed in ancient India and Persia to treat lung diseases. The 
tenth century book, Liber Fundamentorum Pharmacologiae describes the use of copper 
compounds for medicinal purposes in ancient Persia. Powdered malachite was sprinkled 
on boils, copper acetate as well as and copper oxide were used for diseases of the eye and 
for the elimination of "yellow bile." Nomadic Mongolian tribes treated and healed ulcers 
of venereal origin with orally administered copper sulfate. 
Copper is known to be an essential element in human metabolism. However, 
copper does not exist in the body in measurable amounts in ionic form. All measurable 
amounts of copper in the body exist in tissues as complexes with the organic compounds 
of proteins and enzymes. Some copper complexes serve to store copper, others to 
transport it, and yet others play important roles in key cellular and metabolic processes. 
Therefore, it has been concluded that copper becomes and remains intimately involved in 
body processes.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
AIM 
AND 
OBJECTIVES 
 AIM AND OBJECTIVES: 
 
AIM: 
To purify Thurusu (Copper Sulphate) and prepare Thurusu Parpam  using traditional 
siddha methods with detailed study on acute and long term toxicity of “THURUSU 
PARPAM” in animal model (Wister albino rats)  
OBJECTIVE:  
 
1. Purification of THURUSU using siddha literature  
 
2. Preparation of THURUSU PARPAM using siddha literature  
 
3. Chemical analysis of THURUSU PARPAM  
 
4. Toxicity study on “THURUSU PARPAM” using animal models  
 
a. Acute Toxicity 
b. Chronic Toxicity 
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SIDDHA ASPECT 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE: 
 
SIDDHA ASPECT: 
JUR: 
VERNACULAR NAME 
 Arab  : Zajul-alcher 
 English : Basic copper acetate, Blue copper, Blue stone, 
Crude copper sulphate, Copper acetate,  Roman vitriol, Verdigris. 
 Gujarathi : Mor-tuta 
 Hindi  : Nila-thota, Nilatuba 
 Malayalam : Toorshi, Turi  
 Sanskrit : Mayura thutham, Nellatuta, Sikhigrivam, Thutta. 
 Tamil  : Mayil thutham, Tutam, Thurisi 
 Telugu  : Mayilu thuthamu 
NtWngah;fs; 
 fz;lh;> ew;gr;ir> kapy; Jj;jk;  
- Fzghlk; jhJ rPt tFg;G 
 MLq;$j;jd;> Mjr;Rj;JU> MjpFUehjd;> fq;fhsd;> fLq;$j;jd;> 
fz;Zf;Furd;> fz;lH> fUNkfd;> fhrhk;GJHzj;Njhd;> FiyNahd;> 
Fd;iwtpy;yp> $j;jd;> RliyNahd;> eyg;gr;ir>epwKj;jd;> ep\;fsd;> 
ke;jhuhfq;ifNahd;> khy;krpd;dk>; guRghzp> gy;Yf;Nfj;jhd;>  
- Nghfh; epfz;L ml;ltiz gf;fk; 7 
 epyk> ePyk;> ty;fwyk;> mfepyk;> etepyk;> ehkiy> fhpyk;> ryePH. ,jid> 
 
   
“mjPjkhk; epyr;nkd;Wk; ePynkd;Dk; NgU 
   mUspNdhk; mtDf;F vd;Wk; NgU 
  mjPjkhk; tyfwy; vd;Dk; NgU 
  trdpj;Njhk; mfepynkd;Wk; NgU 
  ejPjkhf eyepynkd;Wk; NgU 
  ehkiy fphpynkd;W mjw;Fg; NgU 
  mjPjkhk; rpy ePnud;Wk; NgU 
  mUspNdhk; mjPjg;Ngh; JUR fzpl NgNu”. 
- gQ;r fhtpak; epfz;L gf;fk; 132 
vd;w mbfshy; mwpayhk;. 
 fz;lh;> ePyg;ghzp> ew;gr;ir> fUNkfd;> FUehjd;> ePyf;fs;sp> 
Myg;gilNahdhjp> fliyNahd;.  
,jid> 
 “guR ghzp ghq;fhkiw fz;lh; 
 jhpR epyg;ghzp jdpj;j rpliyNahd; 
 nehpR ew;gr;ir epwKw;w epl;fTs; 
 muR Jq;fhsdhba $j;jNd” 
  
 “$w;wd; nfhiyNahd; Fzid tpy;yf;fp 
 khw;Wkhy; kr;rpdd; khe;jhuh nfq;ifNahd; 
 fhw;whd; fUNgfd; fLk; gy;Yf;Nfw;wtd; 
 Njhw;wf; FUehjd; nrhw; ngah; JhprpNa” 
 
 “ePyf;fs;sp Nehpa fz;lh; jhd; 
 Nfhyytzf; nfhba rptrf;jp 
 MyKila Nahdhjp fliyNahd; 
 khyhs; Nkzpths; gr;ir NkdpNa” 
  
 “Nkdpdth;f; FUFy Ntjhe;j thjpjhd; 
 ghzp rhjhrptd; ghpRj;j ghzpahk; 
 Mzp KlePykhjp kfhFU 
 thsp Jhprpapd; kfj;jhd; ehkNk” 
- rl;lKdp epfz;L 
vd;w mbfshy; mwpayhk;. 
 
 
JUR vd;wiof;fg;gLk; kapy; Jj;jk;> cgurr; ruf;Ffspy; xd;W. ,jid> 
gpd;tUk; nra;Ashy; mwpayhk;.  
“fz;L nfhs;S gurj;jpd; tifiar; nrhy;Ntd;. 
 fhe;j Nkh lg;gpufe; JUR fd;dhH 
 ...................................................................... 
 ......................................................................” 
- Nghfh; Vohapuk; 
 
jhJnghUs; ehd;F gphpTfis cilaJ. mit 
1. cNyhfk; - 11 
2. fhurhuk; - 25 
3. ghlhzk; - 64 
4. cgurk; - 120 
 
 
 
“Nfsg;gh fhunkhL rhue; jhDk; 
 nfl;bah apUgJl dQ;R khr;R 
jhsg;gh TgurE}w; wpUg jhFk; 
jhahd etNyhfk; gjpndhd; whr;R” 
“ehsg;gh ghlhz tifNa njd;why; 
eykhd tWgj;J ehy jhr;R 
#sg;gh tpitnay;yh nkhd;wha;r; Nrh;f;fj; 
njhifAnkhU tpUE}Nwh bUg jhr;Nr” 
- Nghfh; fhurhuj;Jiw 
cgurr; ruf;Ffs; 120 vd;W tifg;gLj;jg;gl;Ls;sJ. ,e;j 
cgurr; ruf;Ffspy; JUrhdJ fhe;jk;> mg;gpufk; ,tw;wpw;F 
mLj;jg;gbahf itf;fg;gl;Ls;sJ. 
fpilf;Fk; ,lk;: 
 JUrhdJ ,aw;ifapy; fpilg;gJ vd;W Fzghlk; jhJ rPt 
tFg;G E}ypy;  fhzg;gLfpwJ. ,e;j fUj;J ahNfhG etuj;d 
rpe;jhkzp vd;w E}ypYk; fhzg;gLfpwJ.  
jw;fhyq;fspy; JUR nraw;if Kiwapy; Ntjpapay; 
Ma;tfq;fspy; nra;ag;gl;L fpilf;fpd;wJ. nraw;ifapy; nrk;Gld; 
fe;jf jpuhtfk; Nrh;j;Jf; fha;r;rp vLj;J cg;ghf;fpf; nfhs;syhk;. 
   
JUR itg;G Kiwfs;: 
JUrhdJ itg;Gg; ghlhzj;jpy; itj;Jr; nrhy;yg;gl;Ls;sJ.  
   ,jid> 
 “ghHf;fNt JhprpnahU itg;Gr;nrhy;yg; 
  gz;ghfr; nrk;ghNy ghisgz;zp 
 fhHf;fNt fy;Yg;Gg; nghbaha;g;gz;zp 
  fhzpJf;Fg; gjpdhwpy; ntbAg;Gr;rPdk; 
  VHf;fNt epWj;je;j ghidapNyNghl;L 
  ,jkhd gor;rhW NkhUk;thHj;J 
 MHf;fNt Nky;%bg; Gijj;Jg;NghL 
  MWjpq;fshd gpd;ngLj; Jg;ghNu.” 
- NghfKdpth; itj;jpafhtpak; 1000 
 
 “jhJ jhd; je;jpukha; rpj;jh; itj;j 
 rhq;fkkhk; Ngiuapdp rhw;wf;NfS 
 .................................................................. 
 .................................................................. 
 jhndd;w uj;j ghlhze; Jj;jk; 
 jhahd JhprpNahL urpjj; ijyk;” 
- Nghfh; Vohapuk; 
 
 
 “fspahd JUrpAlJiuiaf; NfS 
 nrhHg;nghpa ntbAg;G fy;Yg;G rPik 
 xspahd gor;rhW japUthHj;J 
 cj;jNk fUijAl ,e;jk; thHj;J 
 nespthd nrk;ghNy ghj;jpuk; Nghw;gz;zp 
 Neuhd fOijAl nyj;jpNghl;L 
 mopthd G+kpapNy Nghl;L %b 
 MWjpdq;fshd gpd;G naLj;Jg;ghNu”. 
- Nghfh; ruf;F itg;G E}W  gf;fk; 214 
 
“itf;fNt new;ghid jd;dpy; itj;J%b 
 tskhd etehs; nrd; nwLj;Jg; ghU 
If;fNt G+ukJ nfhbaG+u 
kg;gNd apg;G+uk; gjdk; gz;Z 
ief;fNt Jhprpdpl itg;G NfS 
eykhd rPdpAg;G fy;Yg;Gq; $l;b 
ikf;fNt Kiyg;ghY nkUikj;japU 
ike;jNd Rj;j ry %d;WQ; Nrh;j;jiuNa 
 
miuj;jg;gh nrk;Gf;fpz;zp jd;dpy;itj;J 
tg;gNd tha;%b Fopjhd; ntl;b 
tiuj;jg;gh gpz;lj;jp nyUitf; nfhl;b 
tskhff; fpz;zpitj;J vUthy;%b 
kiuj;jg;gh kz;lQ; nrd;wLj;Jg;ghU 
kfj;jhd JhpR ePnud;d nrhy;Ntd; 
epiuj;jg;gh G+rpj;J gjdk; gz;Z 
epr;rkhaj; Jhprpdpl kfj;Jtq;fhNdh” 
    - jd;te;jphp fiyQhdk; 500 gf;fk;:12 
“cfe;J ed;wh apd;dnkhU ruf;Fr; nrhy;Nt 
Dhpiknad;w gr;iralh JhpRg;Nghf;F 
tUe;jped;whr; nrhy;YfpNwhQ; rPdf;fhu 
khHf;fKl dfhudj thq;fpte;J 
cfe;J nra;A ghj;jpuj;jp ypl;Like;jh 
mz;ikAld; gor;rhWe; japUk;thHj;J 
mfj;jpdpNy Fopntl;b rkhjpitg;gha; 
ag;gNd kz;lye;jhd; nrd;W thq;Nf 
 
thq;fp ed;wha; fpz;bajpw; gpd;Dkf;fhs; 
 tskhd gor;rhWe; japUk; thHj;J 
jhq;fped;wha; Fopntl;b Kd;Nghyg;gh 
rkurkha; rhkjpjdpy; itj;Jg;ghU 
ghq;Fngw JhpRepw;F nkd;d nrhy;Ntd; 
gr;irnad;w gr;ir epw kpjw;nft;thJ 
rhq;FKs;s ruf;FfSf; fpJjhdg;gh 
jd;ikAs;sj; JhpR ntF Jhprhk;ghNu.” 
   - uhkNjth; itj;jpa fhtpak; 1000 gf;fk; 194 
 
vd;w mbfshy; mwpayhk;. 
,t;tpjk; fpilf;Fk; JURk;> ,aw;ifapy; ekJ E}y;fspy; 
nrhy;yg;gl;Ls;s JURk; xd;W jhdh vd;gJ Muha;r;rpf;FhpajhFk;. 
 
 
el;G - gif ruf;Ffs;: 
 “ Mkg;gh JURj; JUitf;NfS 
  mlq;fhj apzq;fnshL rPdk;#ld; 
 jhkg;gh mg;gpufk; fy;Yg;Gdhfk; 
  rq;ifAs;s ,e;Jg;GJ tq;fypq;fk; 
 ehl;lKld; fz;lwpe;J ed;ikahf 
  ehkg;gh nrhd;dtf rj;JUNtahFk; 
 Xkg;gh rj;JUthy; Jhpirf; nfhz;L 
  ce;jkNd kpj;JUit ciuf;f NfNs 
 Nfsg;gh Jhprprj;JUit nrhd;Ndd; 
  nfzpjKld; kpj;JUit ed;wha; NfS 
 Msg;gh rhunkhL tPukhpjhuk; 
  mofhd ntz;fhuk; nfe;jp#jk; 
  fhyg;gh G+unkhLkNdhrpiyAk; ypq;fk; 
  fUthd kpj;JUntd; wwpe;J nfhz;L 
 thsg;gh kpj;JUthy; nraNk nra;J 
  khHf;fKld; NtjKiw kfpo;e;JghNu”. 
- mfj;jpah; thj nrskpak; gf;fk; 241 
 “ghug;gh g\hzq; fhurhuk; 
 gjpthd cgurKk; gFe;J ghHj;J 
Neug;gh rj;JUkpj;JU twpe;J 
 Neh;ikAld; ehdlf;f newpiaf;NfS 
Ngug;gh gpyj;jnjhU JhpRjhDk; 
 ngUikAld; fl;Ljw;F rj;JUitf; NfS 
ePug;gh tpzq;fndhL #ld;rPd 
 newpnts;is gh\hz kg;gpufhNk. 
mnkd;w nts;isag;gh \hzq;fy;Y 
 tlq;fhj kpUjhHrpq;F fhe;jk; 
jhnkd;w tpe;Jg;G tq;fehfQ; 
 rth;fhu kpitKjyha;r; rj;JUntd;nwz;Z] 
Nghnkd;w rj;JUthw; nfhz;L Nghl;lhw 
 Gj;jpAl ndOg;gjw;Fg; Gfyf;NfS 
    - uhkNjth; itj;jpa fhtpak; 1000 gf;fk; 226 
   
“khnkd;w kpj;JUit ed;wha;f;NfS 
 eykhdntz;fhuQ; rhuKld;NfNs 
Nfsg;gh thpjhuk; tPuq;nfe;jp 
 nfbahd rpiyg;G+uQ; #jypq;fk; 
ehsg;gh nfThpNah epkpisgz;zp 
  ed;ik ngw kpj;Uit eae;J ghHj;J 
Nfsg;gh thunky; thjk;ghHj;jhw; 
 FzkhF kzkhFq; FUitf;fhU 
Msg;gh thapuj;ij awpe;J ghHj;jhy; 
 mUikAs;s rhunky;yh kwpayhNk”. 
              - uhkNjth; itj;jpa fhtpak; 1000 gf;fk; 227 
“fhzNt kpj;Uitr; nrhy;Ntd; ike;jh 
 fUthd ypq;fKld; nfThpgz;iz 
MzNt epkpisnahL nfThprpiyG+uNk 
 G+uzkhQ; #jnkhL nfe;jptpLk 
NjhzNt ntq;fhuk; rhukhpjhuk; 
 Rj;jKs;s JUrjw;F kpj;Utha; epw;Fk; 
CzNt rj;JUthy; rq;fhuk; gz;zp 
 cj;jkNd kpj;JUth Yfe;JfhNz”. 
 
“ghug;gh rj;JUkpj; JUite;Ak; 
 ghyfNd RUf;fKld; nfhQ;rq;NfS 
Neulh JUR rj;JUitf;NfS 
 eprkhd rTf;fhuk; tq;fk; ehfk 
fhulh ape;Jg;G fhe;jQ;rpq;fp 
 fy;rtL ghlhzq; fy;Yg;Gjhd; 
Nrulh mg;gpuf kpzq;fd;#ld; 
 rptrpth mQ;rdf;fy; rtLnjhl;b” 
                   -mfj;jpah; ghpG+uzk; 1200 gf;fk; 220 
 
 
 gif ruf;Ffs; (rj;U): 
rTl;Lg;G> njhl;bg; ghlhzk;> mQ;rdf;fy;> ntbAg;G> #ld;> 
mg;gpufk;> rPdk;> nts;isg;ghlhzk;> fy;Yg;G> kpUjhH rpq;fp> ,e;Jg;G> 
ehfk;> tq;fk;> rTf;fhuk; Kjypad 
el;G ruf;Ffs;  (kpj;U): 
mhpjhuk;> etr;rhuk;> ntq;fhuk;> tPuk;> fe;jp> #jk;> G+uk;> rpiy> 
nfshp> epkpis> ,ypq;fk; Kjypad. 
 
Rit: 
 Jth;g;G>  ntFl;ly;;. 
gphpT: 
 fhHg;G. 
tPhpak;: 
 ntg;g tPhpak;. 
 vy;yhg; nghUl;fSk; gQ;r G+jkakhdJ. (rpj;jh;fs;  ruf;Ffis 
Ritapd; mbg;gilapy; jhd; G+j $Wghl;il tFj;jpUf;fpd;whHfs;). 
 JUrpd; Rit Jth;g;G vd;gjhy; Jth;g;G = kz; +  fhw;W vdNt 
JUrhdJ gpUjptp> thA G+jj;ij mbg;gilahff; nfhz;lJ. vdNt 
JUrpd; Fzk;> kz; kw;Wk; fhw;W G+jq;fspd; ,aw;if Fzj;ij 
ngWk; vd mwpayhk;. 
nra;if: 
 cly; cukhf;fp - Tonic   -  (1 - 2 cSe;J) 
 the;jpAz;lhf;fp - Emetic  -  (5 - 10 cSe;J) 
 mOfyfw;wp  - Anti septic 
 Gz;Zz;lhf;fp - Caustic   -  (5 - 10 cSe;J) 
 Jth;g;gp  - Astringent -  (1 - 2 cSe;J) 
  
 rpwpa mstpy; Jhprpid nfhLf;f gyfhhp, Jth;g;gpahf nray;gLk;. 
 mjpf mstpy; nfhLf;f  the;jpAz;lhf;fp, Gz;Zz;lhf;fp Mf 
nray;gLk;. 
- gjhHj;j Fztpsf;fk; fz;Zrhkpak; 
 
JUrpd; gz;Gfs;: 
 ,J ePy epwkhf ,Uf;Fk; 
 ,jid nghbf;f gr;irahf ,Uf;Fk; 
 ,J ePhpy; fiuaf; $baJ. 
 Jhprpid jPapypl;lhy; JhprpYs;s ePH ePq;fp gr;irAk; ntz;ikAk; 
fye;j rhayhFk;. 
 jP mjpfkhdhy; mjpypUf;Fk; jpuhtfk; ePq;fp jhkpu epw 
Jfs;fshFk;. 
 ,jw;F xUtpj Jth;g;Gk; ntFl;lYk; cz;L. 
 JhpR fiuj;j ePH; ePy epwkhapUf;Fk;. 
 
JUrpd; Rj;jp Kiwfs:; 
 JUrpid Rj;jp nra;ahky; cs; kUe;jhf gad;gLj;Jk; NghJ eQ;Rf; 
FwpFzq;fis Vw;gLj;Jk; vdNt Rj;jp nra;j gpd;G gad;gLj;j 
Ntz;Lk;. 
 ntz;ikahFk;gb nghhpj;J vLj;jhYk; Rj;jpahFk;. 
     - Fzg;ghlk; jhJ [Pt tFg;G 
 Njitahd Jhprpid nte;ePhpy; fiuj;J tbfl;b Rz;lf; fha;r;rp 
cg;Gf; fl;bdTld; vLj;Jf; nfhs;sTk;. 
  JUrpw;F NjDk; nea;Ak; tpl;liuj;J %irapypl;Lf; fha;r;rp gpwF 
ghy; Khpj;J tbfl;ba ePhpy; 3 ehs; Cw itj;J cyh;j;jp vLj;Jf; 
nfhs;s Ntz;Lk;.  ,q;fdk; Rj;jp nra;j JUR tplf; Fzkpd;wp 
,Uf;Fk;.  the;jpia cz;L gz;zhJ. 
 gRtpd; ePhpy; Jhprpid itj;J vhpj;J fOtpnaLj;J nta;apypy; 
cyh;j;jpf; nfhs;sr; Rj;jpahFk;.  
 “,ak;gpzgr; irj;JUir thq;fpte;J 
    ,ay;ghf gRq;Nfh kaj;jpw;Nghl;L 
    eak;glNt nahpj;njLf;fr; Rj;jpahr;R” 
     - ahf;NfhG itj;jpak;-300 gf;fk; 110 
gr;irj;JUir thq;fp gRq;Nfhkaj;jpy; Nghl;L mLg;Ngw;wp 
vhpj;njLf;fr; Rj;jpahFk;. 
 “JUR Nfhkpaj;jp xU dhNyANyhf tpNghlR” 
- jd;te;jphp Xuz;lj;ijyk; gf;fk;22 
Njitahd JUR Jz;ilg; gRtpd; Nfhkpaj;jpy; xU Cw itj;J 
vLj;Jf;nfhz;lhy; Rj;jpahFk;. 
 “nrhy;Yfpw JURjd;id thq;fpte;J 
RfKlNd japujdp Y}wg;Nghl;L 
 ey;ynjhU japhpdhw; gpd;giuj;J 
  ed;whf tpy;iy jl;b naLj;Jf;nfhz;L 
 nry;yKs;s Xljid mLg;gpNyw;wpj; 
  jpukhfg; Gul;baij vLj;Jf;nfhz;lhy; 
 ,y;ykjp ypijg;Nghy; Rj;jpNtW 
  ,iynad;W ahf;NfhG ,ak;gpdhNw” 
     - ahf;NfhG itj;jpak; -300 gf;fk;16 
 JUir thq;fp japhpY}wg;Nghl;L vLj;J nfhQ;rk; japh;tpl;liuj;J tpy;iy  
jl;b itj;Jf; nfhz;L Xl;il mLg;gpNyw;wp me;j Xl;by; JUR tpy;iyiag; 
Nghl;L gpul;b vLj;J itf;f Rj;jpahFk;. 
 japhpy; xU rhkk; JUir Cwitj;J vLj;Jf;nfhz;lhy; JUR 
Rj;jpahFk;. 
 JUirj; japhpy; miuj;Jf; fUfitj;j Xl;by; Nghl;L gpul;b 
vLj;Jf;nfhz;lhYk; Rj;jpahFk;. 
 
 “kA+uj; Jj;jj;ij td; gRtpd; jd; japuhy; 
 Xahj iuj;jjilNah Nahl;by;iy – J}ajh 
 nthd;Nw Glkpl;lhy; xz;ZjNt maj;JUf 
 ed;whfr; Rj;jahk; ehL”. 
- mfj;jpah; itj;jpa rpe;jhkzp 
 
kapy; Jj;jj;ijg; gRtpd; japhpy; miuj;J milahfj; jl;b Xl;by; itj;J 
%b xU Glkpl;L vLf;f Rj;jpahFk;. 
 “fw;whsQ; NrhW nty;yq; fhWk;gh nda;jhd; tpl;L 
   kw;wij atpj;jhw; Rj;jp kapy;Jj;jk; Mtpd; Nkhhpy; 
   cw;wpl T+witj;jhw; Rj;jpah Kah; ntz;Lj;jk; 
   nrhw;Rz; zhg;GePyp Y}wplr; Rj;jp ahNk” 
    - mkph;jrhfuk;> gjhHj;j #lhkzp gf;fk; 54  
 JUrpid nfhbNtyp rhW rhWtpl;L 3 ehs;ntspapy; itj;J vLf;f 
nts;isaha; Rj;jpahFk; 
- ruNge;jpuh; Fd;kNuhf rpfpl;ir Kiwfs; gf;fk; 270 
 
 
 JUrpd; nghJFzk; 
 “Gz;zhw;Wq;fhkpaj;jpd; Gz;zhw;Wq; fz;Nzhia 
 tpz;Nzw;W Kj;NjhL tPwlf;FQ;-rz;Zfpd;w 
 the;jpnahL Ngjp jUk; tha;Neha; Rue;jzpf;Fq; 
 fhe;jp jUe;Jhprp fhz;”. 
- Fzghlk; jhJ rPt tFg;G gf;fk; 552 
tpuzk;> fhkpatpuzk>; fz;Nzha;> Ruk;> tha;g;gpzp ePq;Fk;. the;jp> Ngjp> 
fhe;jp cz;Lgz;Zk; 
,Nj fUj;J gjhHj;j Fztpsf;fk; vd;w E}ypYk; fhzg;gLfpwJ.  
 “Jj;jKe; JUR khwhg; Gz;Zld; Rthrfhrk; 
 gj;jpu khd fz;zpw; glyNk fhrk; Nghf;FNk 
 cj;jk khdNty; KWthe;jp tpf;fy;ntg;G 
 nkj;jpa RuNk apio tpl;L nkd;Wiug;gh; rpj;jh;” 
     - mkph;jrhfuk; gjhHj;j #lhkzp gf;fk; 94 
 
JUR NrUk; gpw kUe;Jfs;: 
                  JURgw;gk;;: 
“tpiue;JghH fpuhzptif nay;yhe;jPu tpsk;GfpNwd; JUrpdpl gw;gkhHf;fk; 
fiue;Jgw; JUrpnahUfl;bthq;fp fUe;Jsrpr;rhw;wpdpNy A+wpr;rhkk; 
,iue;JNk naLj;je;j ,iyaiuj;J ,ay;ghfj;JURf;Ff; ftrk;G+l;b 
fiue;JNk NaOkz;Znra;J fhzpdQ;rhzfyQ; rJukhf;Nf” 
 
“Mf;fpNa jiuasT fz;lkl;Lk; mofhff; Fopg;Gle;jhd; Nghl;nlLj;J 
Nehf;fpNa fUT+kj;jQ; rhw;whNy EZf;fKld; rhkk;Nghl;nlLj; 
jt;tpiyahy; 
 Njf;fpNa aiuj;JKog; Gle;jhd;Nghl;L Nrh;j;njLf;fg;nghUkpaJ 
ePwpg;NghFk; 
tPf;fpNa Jhprpjidr; rpkpopy;itj;J tpjkhf %bitj;jhy; FUthk;ghNu” 
 
“FUthFk; mjpd;ngUik Ngnrhz;zhJ Ftyaj;jpy; itj;jpah;f;Nf   
iffpl;lhJ 
fUthFk; thjpnad;wh ywpe;J nra;thd; frlhdtapj;jpaNu nra;ahHnra;ahH 
mUthQ; rd;dpRuk;nfz;ilfl;b ml;lFd;kk; gy;yirT thAr;#iy 
jUthFk; apitfhkhiy rhuhJghz;Ltp\ ePHf;NfhitNa”.  
      - NghfKdpth; itj;jpak; 700 
 
JUR FU – ahNfhG FU 
        “JUR Rz;zkhdhy; Nrhjpf;fg; gj;jiuahk;” ,e;jg; 
gonkhop JURf;F kl;LNk cz;L.  JUR Rz;zr; nre;J}uk; 
fsq;F-nrk;G> JUR FU Nghd;wtw;wpd; vz;zw;w nra;Kiwfs; 
rpj;jh; E}y;fspy; nrhy;yg;gLfpd;wd. 
 xU gyk; JURf; fl;biaf; fUe;Jspr; rhw;wpy; xU rhkk; Cwtpl;L 
vLj;Jf; fUe;Jsrpr;rhw;wpy; xU rhkk; Cwtpl;L vLj;Jf; fUe;Jsrp 
,iyia miuj;Jj; JUR fl;bf; ftrk; nra;J cyh;j;jp mjd;Nky; 
kz;rPiy VO nra;J xU rhz; mfy> ePs Moj;jpy; Fopntl;b 
mjpy; mbapy; ,uz;L vUit itj;J mjd;Nky; ftrj;ij itj;J 
mjd;Nky; Fop epiwa vUit mLf;fpy; GlkplTk;.  Mwpagpd; 
gphpj;njLj;Jj; JUirf; fy;tj;jpy; ,l;Lf; fU Ckj;jd; rhWtpl;L 
xU rhkk; miuj;J tpy;iy jl;b cyh;j;jp mjd;Nky; Kg;GFUitg; 
G+rp> fU Ckj;jd; ,iyapd; tpOjpdhy; ftrpj;J mfypy; ,l;L 
Nky; mfy; %b %d;W rPiykz; nra;J KOg;Glkpl;L Mwpa gpwF 
 gphpf;fg; gw;gkhf ,Uf;Fk;.  ,g;gw;gj;ijj; “JUR FU” vd;W $Wth;. 
(ahNfhG FUE}y; -55) 
   - jl;rpzh%Hj;jp FUKfk; 100 (fw;gKg;G FUE}y; 100) 
JUR FU gw;gk; 
         xU gyk; kapy; Jj;jk; nfhz;L te;J rl;bapypl;L 
mLg;Ngw;wp Kg;Gr; nraePuhy; xU ehisf;F 4 ehopif tPjk; 
%d;Wehs; RUf;Ff; nfhLj;Jg; gpwF ,g;gbNa etr;rhu jpuhtfj;jhy; 
%d;Wehl;fs; nra;J ntapypy; fha itj;J ,jd; vilf;Fr; rhpahf 
tq;f Rz;zk; vLj;Jr; ryk; tpl;liuj;J Nkw;gb JURf;Ff; 
ftrQ;nra;J ntapypy; VOehl;fs; cyh;j;jpf; fy;Rz;zhk;G rPiy 3 
nra;J> 5 vUtpw; Glk; Nghl;L xUehs; Mwtpl;L kWehs; gphpj;Jg; 
ghHj;jhy; Rj;j ntz;ikaha; ePwpg; NghFk;.  ,ij vLj;Jg; gjdk; 
gz;zp itj;Jf; nfhs;s Ntz;Lk;.  ,JNt FU gw;gk;. 
   - jl;rpzh%Hj;jp FUKfk; 100 (fw;gKg;G FUE}y; 100) 
 
Jhprp jpuhtfk; 
   
“Mnkd;w JhprpAl jpuhtfj;ijr; nrhy;Ntd; 
   mg;gNd JhprpnahU gye;jhD}W 
  fhnkd;w ntbAg;G gye;jhD}W 
   fyq;fhj rPdkJ gye;jhD}W 
  Ntnkd;w rTl;Lg;G gyKike;J 
   ntUshNj tsfpYg;G gyKike;J 
  jhnkd;w nfe;jpAg;G gyKike;J 
   jaq;fhNj ape;Jg;G gyKikQ;Nr” 
   
   “mQ;NrhL rj;jpnad;w rhuk;gj;J 
   mg;gNd fy;Yg;G gyKk;gj;J 
eQ;NrhL tPukJ gyK%d;W 
 etr;rhuk; uz;L gj;J gyKk;NghL  
gpQ;NrhL fUntq;F gyKnkhd;W 
 Ngrhj thisAg;G cUtpAg;G 
gQ;NrhL kzpAg;G NkdpAg;G 
 gjwhNj xt;nthd;W gyKk;NghNl”. 
 
“Nghl;nly;yhk; guq;fpAl rhuhak;thHj;Jg; 
 nghUe;jNt %d;Wehshl;L Ml;L 
Ml;nly;yhk; utpapypl;L Ie;Jgq;Fgz;zp 
 mg;gNd xUgq;F fyrj;jpl;L 
G+l;nly;yhk; ghiynad;w rl;b%bg; 
 Gfohf kh\j;jhy; rPiynra;J 
%l;nly;yh kLg;Ngw;wp gPq;fhd;itj;J 
 Kaw;rpaha;j; jpuhtfj;ij thq;fplhNa” 
 
“thq;fpl;l jpuhtfj;ij kWruf;fpY}w;wp 
 tskhf utpapypl;L fyrj;jpw;Nghl;L 
Njq;fpl;l jpuhtfj;ij thq;fpj;jPU 
 rpwg;ghf ite;Jju kpg;gbNathq;F 
ghq;fpl;l muf;fhNy Fg;gpg;gz;zpg; 
 gjdkha; %bitj;J ghq;iff;NfS 
Njq;fpl;l ghiwAg;G gy%NuO 
 rpwg;ghf jpuhtfj;jpy; Njha;j;jplhNa” 
  
“Njha;j;JNk jpdNkO utpapw;NghL 
 njhd;ikahk; ntbAg;Gr; rPdf;fhuq; 
fha;j;JNk fly;EiuAQ; #ldpj;J 
 fyq;fhj G+ePw; fhuk;tPuk; 
Nja;j;JNk ethr;rhue; JhpRnts;is 
 rpwg;ghfg; gjpndhd;W jpuhtfj;jpyhl;b 
Va;j;JNk tpy;iyfl;b Ayug;NghL 
 ,jkhf mfypypl;L mtph;g;Glkha;g;NghNl”. 
 
“Glk;NghL miuj;jiuj;J Ie;J jue;jhDk; 
 Gfohf naUntLj;J gj;Jkl;Lk; 
jplk;NghL jpuhtfj;jpy; gye;jhNdO 
 rpwg;ghfg; Glk;Nghl kUe;ijj;jhDk; 
flk;NghL Fok;ghff; fiuj;Jf;nfhz;L 
 fy;Yg;gpy; gprhpay;Nyh fhpNahl;by;thl;L 
elk;NghL Fok;ngy;yhe; Njha;j;Jthl;L 
 eykhf fhpNahl;by; Kjputhl;Nl”. 
 
“thl;bNa ftprpf;F kUe;JNfS 
 tifahf Nawntdw fpspQ;rpy; jd;id 
fhl;bNa Rz;zhk;GQ; rTl;Lkz;Zq; 
 fyq;fhNj jz;zPhpy; fyf;fpf;nfhz;L 
xl;bNa jPnahpj;J tw;wkl;Lk; 
 cj;jkNd Glk;Nghl;Lj; J}sha;g;gz;zp 
ehl;bNa jpuhtfj;jh yiuj;jiuj;J 
  eykhf Ie;JGlk; Nghl;Lj;jPNu”. 
 
“jPuNt Glk;Nghl;l kUe;Jjd;id 
 jpuhtfj; jhyiuj;JUl;b nkOFNghy 
MuNt Kd;Dg;gpy; ftrq;fl;b 
 miuahNj fyrj;jpw; G+ePWitj;J 
CuNt ajpd;NkNy cg;igitj;J 
 cj;jkNd NkYke;j G+ePWNghl;L 
NjuNt rpy;ypl;Lr; rPiynra;J 
 jPHf;fkha;f; nfrGlkha;g; Nghl;Lthq;Nf”. 
 
“thq;fpNa Ag;Ggz;zpg; ghHj;jhy;kf;fhs; 
 tapuk; NghypWfpaJ jq;fk;Nghyhk; 
Xq;fpNa fhpapy;itj;J cUf;fpg;ghU 
 cj;jkNd jq;fk;Nghy; fz;tpl;lhUk; 
Njq;fpNa fhpapy;epd;W fk;kpj;jhdhy; 
 rpwg;ghf Kd;Nghyg; Glj;ijg;NghL 
Vq;fpNa xUtUld; NgrNtz;lh 
 Nkj;jpNa fLq;fhur; Rd;dj;jpY}Nj”.    
 
JUR nraePH: 
   
“Mlyhk; JUnrd;w nraePuhNy 
   mg;gNd JUrJTk; gye;jhd;gj;J 
  #lyhq; nfe;jfe;jhd; gye;jhd;%d;W 
   RlHnfhbahQ; #ldJ gyK%d;W 
   Clyhk; tPukJ gye;jhndhd;W 
   cw;gdkhk; nts;isaJ gyKnkhd;W 
  ePlyhk; G+ePW gyKnkhd;W 
   epr;rakhq; fhukJ gyKnkhd;Nw” 
 
  “xd;whd rj;jpaJ fhRIe;J 
   cw;gdkhe; jhsfKq; fhRiae;J 
  kd;whd rpiyaJTq; fhRiae;J 
   khrw;w rPdkJ fhRiae;J 
  Fd;whd mz;lePH fhRike;J 
   NfhopAl ntz;kyKq; fhRiae;J 
  ntd;whd #jkJ fhRiae;J 
   nka;ahd G+ukJ fhRiae;Nj” 
 
  “fhnriljh ide;jhFk; nts;Suk;G+uk; 
   fdj;jnjhU FUtz;L Ik;gj;njhd;W 
  J}rpiljhd; fy;tj;jpw; nghbaha;g;gz;zp 
   Jtstiu NaOehs; rhuePuhy; 
  khnriljhd; njy;Yg;Nghy; tpy;iygz;zp 
   tskhd fyaj;jpw; Rd;dk;G+rp 
  Mnriljhd; kUe;ijapl;Lr; rPiynra;J 
   Ik;g njUtizj;Jnks;s Glj;ijg;NghNl”. 
  
  “Glk;Nghl;L naLj;JlNd FUTkhFk; 
   Gfohf ehypnyd;W fhuq;$l;b 
  jplk;Nghl;Lf; fy;tj;jpypl;L Ml;br; 
    rPuhf ehy;rhkkhl;L Ml;L 
  jlk;Nghl;L mz;Nlhl;b ypl;b%br; 
   rhHghfg; Glk;Nghl;Lg; gdpapy;itf;f 
  elk;Nghl;L MWNghy; nraePuhFk; 
   eykhf tpe;ePhpy; tPuk;NghNl”. 
 
  “tPukpl;lhy; rptg;ghFQ; nraePuhg;gh 
   tPWgl;l #jkJ kjthidf; Ff;fUk;G 
  Mukpl;l GypifapyhL Nghy 
   mah;e;JNghFQ; nraePiuf; fz;lTldg;gh 
  fhukpl;l #jj;ijf; fy;tj;jpl;Lf; 
   fbanjhU nraePuhy; %d;Wehshl;l 
  J}ukpl;l ntz;nziag; NghyhFk;ghU 
   Jbahd kj;jq;fha;f;Fs; itj;Jthl;Nl”. 
 
  “thl;bNa NaOGlk; Nghl;nlLj;J 
   thpiraha;f; fuz;bjdp nyz;nza;Fj;jpAUf;fpg; 
  G+l;bNa naLj;Jg;ghH ej;jj;J kPd;Nghy; 
   Gfohfg; gspr;nrd;W kzpAkhFk; 
  Cl;bNa cgruq;fs; E}w;wpuz;Lgj;J 
   cj;jkNd gh\hz kWgj;JehY 
  jPl;bNa ytztif apUgj;ije;J 
   jpwkhf eth\;bdk; etNyhfj;J}Nl”. 
 
  “Cl;LNk rj;njLj;J tpLtpj;jhf;fh 
   Yj;jkNd rhuiz jhndhd;Nwahr;R 
   G+l;LNk apg;gbNa ,Ugj;njhd;W 
   Nghf;fhd rj;njLj;Jf; nfhLj;Jff;fpy; 
  Ml;LeP R&gnkd;w Fspifahr;R 
   mz;lKjy; gjq;fnsy;yh epikf;Fs;Gf;fp 
  Fl;LeP kPz;LtUq; FspifNtfQ; 
   RUgrpj;Jq; ftdrpj;JQ; RUf;fk;ghNu”. 
 
JUR gpsh];jphp 
“mfj;jp lhkzf; nfz;nza; nkOFld; 
jfj;jplh kWj;J nts;isj; J}s;rkd; 
,fj;jplh rl;byp ypl;Lg; gpy;iyia 
kfj;jplh AUf;fp tb nra;jpNl” 
 
    Mnkzf;nfz;nza;> nkOF ,Nj msT nts;isj;J}s;> 
rl;bapy; Nkw;gb nghUl;fis ,l;L mLg;Ngw;wp cUf;fp tbfl;bL. 
 
“nra;alh JURg; nghbf; fhw;gyk; 
ikalh nrhhpe; jhl;b type;jgpd; 
Ja;alh tYr;rPiyap Y}l;bNky; 
nka;alh uzNk tpLk; Ntz;bNl” 
         tbfl;bdJld; JhpRg;nghb fhy;gyk;> $l;b ed;whf fye;J 
Jzpapypl;L uzj;jpd; kPJ itj;Jf; fl;l uzk; FzkhFk;. 
      - Njiuah; itj;jpak; 1000 
 
 
 
 JUR NrUk; gpw kUe;Jfs;: 
 JUR FU       -jpU%yh; fUf;fpil itj;jpak; gf;fk; 111 
 JUR FU       - NghfKdpth; 7000 f;F #];jpuk; 700 gf;fk;37 
 JhpR FU      - mfj;jpah; itj;jpa uj;d RUf;fk; gf;fk; 145 
-Nghfh; %d;whtJMapuk; gf;fk; 77 
 JhpR fsq;F      - Nghfh; Vohapuk; gf;fk; 49 
 
 JUR Rz;zk;     - jd;te;jphp fiyQhdk; -gf;fk; 18 
-jpU%yh;; fUf;fil itj;jpak; gf;fk; -147 
-,uhkNjth; itj;jpa fhtpak; - 1000 gf;fk; 13 
-mfj;jpah; ghpG+uzk; - 1200 gf;fk; 221 
-A+fpKdp thjhq;f jPl;ir tpjp gf;fk; - 52 
 Jthjr nre;J}uk; -mfj;jpah; itj;jpa gps;is jkpo; gf;fk; 7 
 JUR khj;jpiu  - ruNge;jpuh; itj;jpa Kiwfs; [;tuNuhf 
rpfpl;ir   gf;fk; 58 
 JUR nrk;G       - Gyj;jpah; thj #j;jpuk; - 300 gf;fk; - 21 
- mfj;jpah; gs;S ,UE}W gf;fk; 128 
 -Nghfh; ehd;fhtJMapuk; gf;fk; 150 
 JUR nre;J}u nrk;G  - Gyj;jpah; Qhd #j;jpuk; gf;fk; 35 
 JhpR Rz;z n[aePH  - mfj;jpah; thj nrskpak; gf;fk; 243 
 JhpR n[aePH    - Nghf Kdpth; 7000 f;F #j;jpuk; 700 gf;fk; 117 
 
 JUR jpuhtfk;   - NghfKdpth; 7000f;F #j;jpuk; 700 gf;fk; 82 
- Nghfh; ruf;F itg;G gf;fk; 101 
 
tplf;fbf;fhd kUe;Jfs;: 
  rQ;rPtpf;Fok;G 
 #lhkzp khj;jpiu 
 guQ;Nrhjp Fok;G 
 guzp kUe;J 
 kfhrpe;jhkzp Fok;G 
- tp\ itj;jpa rpe;jhkzp 
 
mQ;rdk;;: 
 ePyj;JUR> Jj;jk;> ntq;fhuk;> #jk;> thsg;gUg;G> mhpjhuk; ,itfs; 
tifnahd;Wf;F tuhfndil xd;W.  ,itfis Nga;g;gPHf;fpiyr; 
rhw;why; miuj;J khj;jpiuahfr; nra;J nfhz;L gzntil 
ntw;wpiy rhw;wpyhtJ> Nga;g;gPHf;fpiyr; rhw;wpyhtJ ciuj;J 
tpopapy; jPl;l m\;l ehfk; Kjypa tp\n[e;Jf;fspd; fbahy; 
mlq;fpd caph; kPSk;. 
       - tp\ itj;jpa rpe;jhkzp 
fz;Neha; kUe;Jfs;: 
 Klkaph;f;fspk;G 
 ,sePHf;Fok;G 
 rq;fhjp khj;jpiu 
Nghd;w fz;Neha; kUe;JfspYk; JUR Nrh;f;fg;gLfpwJ. 
    - Fzghlk; jhJ rPt tFg;G gf;fk; 555 
 ,uj;jpdhjp khj;jpiu 
 fdfhjp khj;jpiu 
 jhk;gpuhjp khj;jpiu 
 gr;ir khj;jpiu 
 re;jpNuhja cUz;il 
  nrhHz jhk;gpuhjp cUz;il 
- ruNge;jpuh; eadNuhf rpfpr;ir  
 
gr;ir vz;nza;: 
Ckj;ijr; rhW 21/2 gbapy; (5 ypl;lh;) JhpRj;J}s; 10 gykpl;L (350 fpuhk;) 
fiuj;J> Njq;fha; nea; 1 gb (2 ypl;lh;) $l;b mLg;Ngw;wp vhpj;Jf; fLF jpuSk; 
gf;Ftj;jpy; ,wf;fpf; nfhs;sTk;. 
 ,j;ijyj;ij rPiyY}l;bg; gytifg;gl;l tpuzq;fSf;F itj;Jf; fl;lTk;.  
,uh[ gpsitf;F cgNahfpf;f ew;gyid mspf;Fk;. 
 fhjpy; cz;lhk; tpuzq;fSf;F rPtbjYf;Fk; NkNy jltp tuf; Fzj;ijf; 
nfhLf;Fk;. 
- Fzghlk; jhJ rPt tFg;G gf;fk; 555 
gr;ir vUit   -  mfj;jpah; uz itj;jpak; 
 
fUT+kj;ij  
DATURA METEL 
FAMILY: SOLANACEAE 
“tpe;jpujq; fl;Lnkopd; NkdpjUq; F\;lnkhL 
te;j tpaHg;ghpg;G khw;Wq;fhz; - Ke;jg; 
kj;jQ; nra;Ruj;ijg; Nghf;Fq; fag;ghq; 
fUT+kj;jk; ed;%yp fhz;” 
 ,J Rf;fpyj;ijAk;> ghjurj;ijAk; fl;Lk;.  clYf;F moif 
cz;lhf;Fk;.   tpah;it> jpdT> gapj;jpak;> Ruk; ,it ePq;Fk;. 
      - gjhHj;j Fzrpe;jhkzp gf;fk;:82 
  
Figure 1: Datura metal 
  
Figure 2: Trichodesma indicum
 
 
  
kiyj;Njd;  
“IapUk yPistpf;f yf;fpg;Gz; ntg;Gly;Neha; 
iga nthopAk; grpAKWk; - itafj;jpy; 
vz;Zkpir ahkUe;jpw; Nfw;w tDghdk; 
ez;Zkiyj; Njndhw;wp dhy;”  
 kiyapypUf;Fk; FwpQ;rpj; Njdpdhy; rpNyl;Lk; fhrk;> Rthrk;> tpf;fy;> 
fz;Neha;> Ruk;> cly;fLg;G ,it ePq;Fk;. 
 ey;ygrpnaLf;Fk;> Fuy;tsk; ngWk;.  kUe;Jz;z Jiz kUe;jhfg; 
gad;gLk. 
,Q;rpr;rhW  
GINGIBER OFFICINALE 
ZINGIBERACEAE 
 “,Q;rpf;fpoq;F ,Uky;[ak; Xf;fhsk; 
 tQ;rpf;FQ; rd;dpRuk; td;Ngjp – tpQ;Rfpd;w 
 #iyaWk; thjk;Nghe; J}z;lhj jPgdkhk; 
 NtiyAWq; fz;Nzha; tpsk;G” 
 ,Q;rpahdJ> ,Uky;> fgk;> Xf;fhsk;> rd;dpRuk;> fbaNgjp> #iy> thjk; 
,tw;iwg; Nghf;fpg; grpia cz;lhf;Fk;. 
     - mfj;jpah; Fzthflk;  
 “,Q;rpapd; FzNk njd;wpay;Gl Diuf;ff; NfsPH 
 mQ;rpLQ; rd;dpnay;yh kfd;wpLk; gpj;j Njhlk; 
 neQ;rpdp ypUkw; Nfhio nefpo;e;jpLk; fgq;fs; jd;id 
 kpQ;rpdp tUNkh ntd;W tpsk;gpLk; NjtE}Ny” 
                  - VL 
 tapw;Wtyp> tapw;WnghUky;> the;jp> Fly;Neha; Kjypa Neha;fSf;F ,ij 
NjD}wy; nra;J nfhLf;fyhk;. 
      - Fzghlk; nghUl;gz;G E}y; 
SOLANUM SURATTENSE 
FAMILY: SOLANACEAE 
 
  
CARUM COPTICUM 
FAMILY : APIACEAE       
      
   
PIMPINELLA ANISUM 
FAMILY : APIACEAE       
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 MODERN ASPECTS: 
IUPAC NAME:  Copper II Sulphate 
OTHER NAMES:  Cupric sulphate 
          Blue vitriol(penta hydrate) 
          Blue stone(penta hydrate) 
          Bonattite(tri hydrate mineral) 
          Boothite(hepta hydrate mineral) 
          Chalcanthite(penta hydrate mineral) 
          Chalcocyanite(mineral) 
PROPERTIES: 
 Molecular formula:  CuSo4   
 Molecular mass     :  159.62 g/mol(anhydrous) 
    249.70 g/mol(penta hydrate) 
 Appearance        : Grey-white(anhydrous)  
Blue (penta hydrate) 
  Density       : 3.603 g/cu.cm(anhydrous) 
    2.284 g/cu.cm(penta hydrate) 
 Melting point       : 110
0
c(.4H2O) 
    150
0
c(423k)(.5H2O) 
    <650
0
c decomp. 
 Solubility in Water: Anhydrous 
    243 g/L (0
0
c) 
    320 g/L (20
0
c) 
    618 g/L (60
0
c) 
    1140 g/L (100
0
c) 
  
Penta hydrate 
    316 g/L (0
0
c) 
    2033 g/L (100
0
c) 
     
 Solubility : Anhydrous 
    insoluble in ethanol 
    Penta hydrate 
    soluble in methanol 
    10.4 g/L (18
0
c) 
    Insoluble in ethanol 
   Refractive index (nD): 1.733 (anhydrous) 
    1.514 (penta hydrate) 
 
STRUCTURE 
        Crystal structure: Orthorhombic (chalcocyanite) 
    Space group Pnma, oP24, 
    a = 0.839nm, b = 0.669nm, c = 0.483nm 
    Triclinic (penta hydrate) 
    Space group P1, aP22, 
     a = 0.5986nm, b =0.6141nm, c = 1.0736 nm 
    α = 77.333
0
,
 β = 82.2670, γ = 72.567 
LD50       :  300mg/kg(oral, rat) 
    87mg/kg(oral, mouse) 
    470mg/kg(oral, mammal) 
  
RELATED COMPOUNDS 
Other cations:  Iron(II) sulphate 
   Manganese(II) sulphate 
   Nickel(II) sulphate 
   Zinc sulphate 
Copper(II) sulphate, also known as cupric sulphate or copper sulphate is the  
chemical  compound with the chemical formula CuSo4. This salt exists as a series of 
compounds that differ in their degree of hydration. The anhydrous form is a pale green or 
grey-white powder, where as the pentahydrate (CuSo4.5H20), The most commonly 
encountered salt, is bright blue. CuSo4.5H2O is in a shade of blue, and very toxic to the 
environment, irritating to the eyes and skin, and also can be harmful if swallowed. 
Copper(II) sulphate exothermically dissolves in water to give the aqua 
complex[Cu(H2O)6], which has octahedral molecular geometry and is paramagnetic. 
Other names copper(II) sulphate are “blue vitirol” and “blue stone”. 
PREPARATION AND OCCURENCE  
Copper sulphate is produced industrially by treating copper metal with hot 
conc.sulphuric acid or its oxides with dilute sulphuric acid. For laboratory use, copper 
sulphate is usually purchased. 
The anhydrous form occurs as a rare mineral known as chalcocyanite. The 
hydrated copper sulphate occurs in nature as chalcanthite(pentahydrate), and two more 
rare ones are; bonittite(trihydrate) and boothite(hepta hydrate). 
CHEMICAL PROPERTIES 
 Copper(II)sulphate pentahydrate decomposes before melting at 150
0
C(302
0
F), 
losing two water molecules at 63
0
C(145
0
F), followed by two more at 109
0
C(228
0
F) and 
the final water molecule at 200
0
C(392
0
F). 
Dehydration proceeds by decompostion of the tetra aqua copper(2+) moiety, two 
opposing aqua groups are lost to give di aqua copper(2+) moiety. The second dehydration 
step occurs with the final two aqua groups are lost. Complete dehydration occurs when 
the only unbound water molecule is lost. 
At 650
0
C(1202
0
F), copper(II)sulphate decomposes into copper(II)oxide (CuO) 
and sulphur tri oxide(So3).  
Its blue colour is due to water of hydration. When heated in an open flame the crystals are 
dehydrated and turn greyish-white. 
Copper sulphate reacts with conc. Hydrochloric acid very strongly. In the reation the blue 
solution of copper(II) turns green due to the formation of tetra chloro cuprate(II): 
Cu
2+ 
+ 4Cl
- → CuCl4
2- 
It also reacts with more reactive metals them copper (e.g. Mg, Fe, Zn, Al, Sn, Pb, etc.,): 
 CuSo4 + Zn + H2O→ ZnSo4 + CuO + H2 
 CuSo4 + Fe + H2O→ FeSo4 + CuO + H2 
 CuSo4 + Mg + H2O→ MgSo4 + CuO + H2 
 CuSo4 + Sn + H2O→ SnSo4 + CuO + H2 
 3CuSo4 + 2Al + 3H2O→ Al2(So4)3 + 3CuO + 3H2 
In addition of being very exothermic reactions, they all produce hydrogen gas. 
The copper formed is deposited on the surface of the other metal. The reaction stops 
when no free surface of the metal present any more.  
 USES 
  As a herbicide, fungicide and pesticide : 
Copper sulphate pentahydrate is a fungicide. However, some fungi are capable of 
addapting to elevated level of copper ions. Mixed with lime it is called Bordeaux 
mixture and used to control fungus on grapes, melons and other berries. Another 
application is Cheshunt compound, a mixture of copper sulphate and ammonium 
carbonate used in horticulture to prevent damping off in seedlings. Its use as a herbicide 
is not agricultural, but instead for control of invasive aquatic plants and the roots of plants 
near pipes containing water. It is used in swimming pools as an algaecide. A dilute 
solution of copper sulphate is used to treat aquarium fish for parasitic infections, and is 
also used to remove snails from aquariums. Copper ions are toxic to fish, so care must be 
taken with the dosage. Most species of algae can be controlled with very low 
concentrations of copper sulphate. Copper sulphate inhibits growth of bacteria such as 
Escherichia coli. 
For most of the twentieth century, chromated copper arsenate (CCA) was the 
dominant type of wood preservation for uses other than deep driven piles, utility poles, 
and railroad ties. To make pressure-treated wood, a large cylinder is filled with 
an aqueous chemical bath. Copper sulfate pentahydrate is dissolved in the water along 
with other additives prior to the lumber being placed inside the cylinder. When the 
cylinder is pressurized, the chemicals are absorbed by the wood, giving the wood 
fungicidal, insecticidal, and UV-light-reflecting properties that help preserve it. 
NICHE USES 
Being a relatively benign and cheap reagent, copper(II) sulfate has attracted many 
niche applications over the centuries. 
 Analytical reagent 
Several chemical tests utilize copper sulfate. It is used in Fehling's 
solution and Benedict's solution to test for reducing sugars, which reduce the soluble blue 
copper(II) sulfate to insoluble red copper(I) oxide. Copper(II) sulfate is also used in 
the Biuret reagent to test for proteins. 
Copper sulfate is also used to test blood for anemia. The blood is tested by 
dropping it into a solution of copper sulfate of known specific gravity – blood which 
contains sufficient hemoglobin sinks rapidly due to its density, whereas blood which does 
not floats or sinks less rapidly. 
In a flame test, its copper ions emit a deep green light, a much deeper green than 
the flame test forbarium. 
In the presence of chlorine, copper ions emit a deep blue light. 
Organic synthesis 
Copper sulfate is employed in organic synthesis. The anhydrous salt catalyses the 
transacetylation in organic synthesis. The hydrated salt can be intimately mingled 
with potassium permanganate to give an oxidant for the conversion of primary alcohols. 
Chemistry education 
Copper sulfate is a commonly included chemical in children's chemistry sets and 
is often used to grow crystals in schools and in copper plating experiments. Because of its 
toxicity, it is not recommended for small children. Copper sulfate is often used to 
demonstrate an exothermic reaction, in which steel wool or magnesium ribbon is placed 
in an aqueous solution of CuSO4. It is used in school chemistrycourses to demonstrate the 
principle of mineral hydration. The pentahydrate form, which is blue, is heated, turning 
the copper sulfate into the anhydrous form which is white, while the water that was 
 present in the pentahydrate form evaporates. When water is then added to the anhydrous 
compound, it turns back into the pentahydrate form, regaining its blue color, and is 
known as blue copper.
  
Copper (II) sulfate pentahydrate can easily be produced by 
crystallization from solution as copper (II) sulfate is quite hygroscopic. 
In an illustration of a "single metal replacement reaction", iron is submerged in a 
solution of copper sulfate. Upon standing, iron reacts, producing iron (II) sulfate, and 
copper precipitates. 
Fe + CuSO4 → FeSO4 + Cu 
Medical Uses 
Copper sulfate was also used in the past as an emetic.
 
It is now considered too 
toxic for this use.
 
It is still listed as an antidote in the World Health Organization's 
Anatomical Therapeutic Chemical Classification System. 
Etching 
Copper sulfate is also used to etch zinc plates for intaglio printmaking. 
Dyeing 
Copper sulfate can also be used as a mordant in vegetable dyeing. It often 
highlights the green tints of the specific dyes. 
TOXICOLOGICAL EFFECT: 
Copper sulfate is an irritant. The usual routes by which humans can receive toxic 
exposure to copper sulfate are through eye or skin contact, as well as by inhaling powders 
and dusts. Skin contact may result in itching or eczema. Eye contact with copper sulfate 
can cause conjunctivitis,inflammation of the eyelid lining, ulceration, and clouding of 
the cornea. 
 Upon acute oral exposure, copper sulfate is only moderately toxic. According to 
studies, the lowest dose of copper sulfate that had a toxic impact on humans is 
11 mg/kg. Because of its irritating effect on the gastrointestinal tract, vomiting is 
automatically triggered in case of the ingestion of copper sulfate. However, if copper 
sulfate is retained in the stomach, the symptoms can be severe. After 1–12 grams of 
copper sulfate are swallowed, such poisoning signs may occur as a metallic taste in the 
mouth, burning pain in the chest, nausea, diarrhea, vomiting, headache, discontinued 
urination, which leads to yellowing of the skin. In cases of copper sulfate poisoning, 
injury to the brain, stomach, liver, or kidneys may also occur. 
 
USES OF COPPER SULPHATE 
Copper sulphate, blue stone, blue vitriol are all common names for pentahydrated 
cupric sulphate, CuSO45H2O, which is the best known and the most widely used of the 
copper salts. Indeed it is often the starting raw material for the production of many of the 
other copper salts. 
Today in the world there are more than 100 manufacturers and the world's 
consumption is around 200,000 tonnes per annum. It is estimated that approximately 
three-quarters of this is used in agriculture, principally as a fungicide, but also for treating 
copper-deficient soils. 
Copper sulphate is a very versatile chemical with as extensive a range of uses in 
industry as it has in agriculture. Its principal employment is in agriculture, and, up to a 
generation or so ago, about its only uses in industry were as a mordant for dyeing and for 
electroplating. Today it is being employed in many industrial processes: 
  The synthetic fibre industry has found an application for it in the 
production of their raw material. 
 The metal industry uses large quantities of copper sulphate as an 
electrolyte in copper refining, for copper coating steel wire prior to wire 
drawing and in various copper plating processes. 
 The mining industry employs it as an activator in the concentration by 
froth flotation of lead, zinc, cobalt and gold ores. 
 The printing trade takes it as an electrolyte in the production of electrotype 
and as an etching agent for process engraving. 
 The paint industry uses it in anti-fouling paints and it plays a part in the 
colouring of glass. 
Indeed, today there is hardly an industry which does not have some small use for 
copper sulphate. In the table below, some of the many uses of copper sulphate are listed. 
Classification - Application 
1.Agriculture 
Major uses 
 Preparation of Bordeaux and Burgundy mixtures for use as fungicides 
 Manufacture of other copper fungicides such as copper-lime dust, tribasic copper 
sulphate, copper carbonate and cuprous oxide 
 Manufacture of insecticides such as copper arsenite and Paris green 
 Control of fungus diseases 
 Correction of copper deficiency in soils 
 Correction of copper deficiency in animals 
  Growth stimulant for fattening pigs and broiler chickens 
 Molluscicide for the destruction of slugs and snails, particularly the snail host of 
the liver fluke 
Other uses 
 Seed dressing 
 Soil steriliser, e.g. Cheshunt compound (a mixture of copper sulphate and 
ammonium carbonate) to prevent "damping-off" disease of tomato, etc. 
 Control and prevention of foot rot in sheep and cattle 
 Bacteriastat for addition to sheep dips 
 Disinfectant in prevention of the spread of swine erysepelas and white scours in 
calves 
 Control of scum in farm ponds 
 Plant nutrient in rice fields 
 Preservative for wooden posts, wooden buildings, etc. 
 Preservative for wooden fruit boxes, planting baskets and other containers 
 Ingredient of vermin repellents, e.g. for application to bark of trees against rabbits 
 Stimulant of latex yield on rubber plantations 
 Protection against algal growths on flower pots 
2. Public health and medicine 
 Destruction of algal blooms in reservoirs and swimming pools 
 Prevention of the spread of athletes foot in warm climates, by incorporation in the 
flooring mixture of swimming baths 
  Control of bilharzia in tropical countries, as a molluscicide 
 Prevention of malaria, in the preparation of Paris green for use against osquito 
larvae 
 Antiseptic and germicide against fungus infections 
 Catalyst or raw material for the preparation of copper catalysts used in the 
manufacture of pharmaceutical products 
3.Industry 
Adhesives 
 Preservative in casein and other glues 
 Additive to book binding pastes and glues, for insecticidal purposes 
 Additive to animal and silicate glues to give water resistance 
Building 
 Timber preservative and in the preparation of other wood preservatives, e.g. oil 
based copper naphthenates and water based copper/chrome/arsenic for the 
prevention of woodworms and wood rots 
 Ingredient of plaster to prevent fungus infection, e.g. to prevent the spread of dry 
rot 
 Ingredient of concrete, both as a colouring matter and as an antiseptic, e.g. for use 
in and around swimming pools 
 Modification of the setting of concrete 
 Protection against lichens, moulds and similar growths on asbestos cement 
roofing and other building materials 
  Control of the growth of tree roots in sewers 
Chemical 
 Preparation of catalysts for use in many industries 
 Purification of gases, e.g. removal of hydrogen chloride and hydrogen sulphide 
 Precipitation promoter in purifying zinc sulphate solutions 
 Precipitation of alkaloids as double salts from crude extracts 
 Source of other copper compounds such as copper carbonate silicate/arsenite/  
aceto-arsenite/resinate/stearate/tartrate/oleate naphthenate/chromate/chlorate/ 
alginate/fluoride/hydroxide, cuprous oxide/ chloride/cyanide and cuprammonium 
compounds 
Decorative trades 
 Colouring glass 
 Colouring cement and plaster 
 Colouring ceramic wares 
 Alteration of metal colours, e.g. darkening of zinc, colouring aluminium 
Dyestuffs 
 Reagent in the preparation of dyestuffs intermediates 
 Catalyst or raw material for the preparation of copper catalysts, e.g. preparation of 
phenols from diazo compounds, preparation of phthalocyanine dyes 
 
 Leather 
 Mordant in dyeing 
 Reagent in tanning processes 
Metal and electrical 
 Electrolyte in copper refining 
 Electrolyte in copper plating and electro forming 
 Electrolytic manufacture of cuprous compounds, e.g. cuprous oxide 
 Constituent of the electrodes and electrolytes in batteries 
 Electrolyte in the manufacture of copper powder 
 Electrolyte in aluminium plating and anodising 
 Copper coating steel wire, prior to wire drawing 
 Pickling copper wire, etc., prior to enamelling 
 Providing a suitable surface for marking out iron and steel 
Mining 
 Flotation reagent in the concentration of ores, e.g. zinc blende 
Paint 
 Raw material for the manufacture of copper naphthenate and other copper 
compounds for use in anti-fouling paints 
 Preparation of certain varnish or paint dryers, e.g. copper oleate, copper stearate 
 Preparation of certain pigments, e.g. copper chromate, copper ferrocyanide, 
copper phthalocyanine 
 Printing 
 Etching agent for process engraving 
 Electrolyte in the preparation of electrotype 
 Ingredient of printing inks 
Synthetic rubber and petroleum 
 Preparation of catalysts used in cracking certain gaseous and liquid petroleum 
 Fractions 
 Preparation of cuprous chloride, used in the purification of butadiene and in the 
separation of acetylene derivatives 
 Preparation of catalysts used in chlorinating rubber latex 
 Purification of petroleum oils 
Textiles 
 Preparation of copper compounds for rot-proofing canvas and other fabrics 
 Rot-proofing sandbags 
 Mordant, especially in calico printing 
 Cuprammonium process for the production of rayon 
 Production of aniline black and diazo colours for dyeing 
 "After coppering" to increase the fastness of dyes 
 Catalyst in the manufacture of cellulose ethers and in cellulose acetylation 
Miscellaneous 
 Improving the burning qualities of coke 
  Laboratory analytical work 
 Ingredient of laundry marking ink 
 Dyeing of hair and horn 
 Ingredient of hair dyes of the phenylene diamine or pyrogallol type 
 Preparation of chlorophyll as a colouring material for food stuffs 
 Imparting a green colour in fireworks 
 Activator in the preparation of active carbons 
 Preservative for wood pulp 
 Preservation of fishing nets and hides on trawls 
 Obtaining a blue-black finish on steel 
 Treatment of carbon brushes 
 Ingredient of the solution used for preserving plant specimens in their natural 
colours 
 Impregnation in fruit wrapping papers to prevent storage rots 
COMPLICATIONS AND MANAGEMENT OF ACUTE COPPER 
SULPHATE POISONING 
                 Copper sulphate is an easily accessible chemical in Sri Lanka that is sold over 
the counter. It is commonly used as a pesticide, in leather industry and also in making 
home-made glue. Burning of copper sulphate in houses and shops (as a good luck charm 
and for religious activities) is a common practice among Buddhists and Hindus. The 
marine blue colour of the hydrated form of copper sulphate crystals is attractive to 
children and is a reason for inadvertent poisoning. However, many admissions due to 
copper sulphate poisoning in adult medicine are acts of deliberate self harm. Ingestion of 
significant quantities of copper carries a risk of multi organ failure and death . 
 Unfortunately, many physicians are not familiar with the complications and management 
of this unusual form of poisoning that has become a rarity. We share our experience in 
treating two such patients and discuss the clinical manifestations, management issues and 
suggestions for prevention. 
Ingestion of more than 1 g of copper sulphate results in manifestation of 
symptoms of toxicity. However, this is only a rough threshold for toxicity and depends on 
individual factors. Mortality in cases of severe poisoning is high and the lethal dose of 
ingested copper sulphate is between 10-20 g . 
The clinical manifestations of copper sulphate poisoning include; erosive 
gastropathy, intravascular haemolysis, methaemoglobinaemia, hepatitis, acute kidney 
injury and rhabdomyolysis. Arrhythmias and seizures are also reported probably 
secondary to other organ system involvement. 
Common gastrointestinal manifestations of copper poisoning are predominantly 
due to corrosive injury. Haematemesis and melaena are observed with severe overdose 
probably due to bleeding from mucosal injury. Liver gets damaged early in copper 
poisoning as the majority of absorbed copper is deposited in liver after being delivered 
from the portal circulation. Acute liver failure following tissue necrosis can occur due to 
direct copper toxicity . 
Two major haematological manifestations of copper sulphate poisoning are 
intravascular haemolysis and methaemoglobinaemia. Intravascular haemolysis can start 
as early as within the first 24 hours since ingestion and is due to the direct oxidative 
damage to erythrocyte membranes. The haemolysis can be rapid and severe with drastic 
drops in the haemoglobin level. The Cu
2+ 
ion oxidizes the Fe
2+ 
ion in haemoglobin to 
Fe
3+ 
resulting in its conversion to methaemoglobin. This manifests as cyanosis and loss of 
oxygen carrying capacity of blood. 
 Acute kidney injury is a much commoner manifestation of toxicity with some 
case reports having an incidence as high as 40-60% . The possible mechanisms of kidney 
damage include; pre-renal failure due to dehydration (vomiting, diarrhea, reduced fluid 
intake), haemoglobinuria, sepsis, rhabdomyolysis, direct copper toxicity on proximal 
tubules and secondary effects of multi organ dysfunction. The recovery of renal function 
following copper sulphate ingestion is observed to be slow and incomplete. In the first 
patient it took nearly 5 weeks before he was independent of dialysis. 
The severe epigastric pain (unusual for gastropathy alone) and elevated amylase 
level in the first patient indicated the possibility of acute pancreatitis. It is not a 
recognized complication of copper sulphate poisoning. However, a rise in serum amylase 
cannot be attributed to pancreatitis alone (even acute kidney injury is associated with a 
rise in serum amylase) and we could not perform a CT scan with intravenous contrast in 
the acute phase of illness due to the renal impairment. Therefore, in this patient, 
pancreatitis could not be confirmed. This observation has also been reported by Gunay et 
al  previously in a single patient of a case series. We suggest that serum amylase level 
should be monitored carefully in patients with copper sulphate poisoning and the 
possibility of acute pancreatitis must be considered though it may be difficult to confirm 
it by imaging due to concurrent renal failure. 
The management of copper sulphate poisoning centers on four key principles; a) 
reducing absorption b) close observation for complications c)supportive therapy and d) 
chelation therapy to remove active copper from the body. 
After ingestion, the contact damage to mucosa can be minimized by drinking 
large quantities of milk and water . Dilution reduces the direct mucosal injury. Emesis 
must be avoided as repeated exposure of the oesophagus to the corrosive agent may 
inflict further damage on the mucosa. Some authors recommend the use of activated 
 charcoal (50 grams dissolved in 200 ml of water, administered in multiple doses if 
necessary at 6 hourly intervals) to reduce absorption, but it is of unproven benefit. 
All complications mentioned above must be monitored for from the first 24 hours 
onwards (daily full blood counts, serum electrolytes, liver and renal function tests). If the 
patient had vomited, aspiration pneumonia or a chemical pneumonitis should be 
anticipated. It would be worthwhile to have a baseline chest roentgenogram in this 
regard. Evidence for haemolysis must be looked for with daily blood pictures and 
reticulocyte counts. If the patient is having spontaneous bleeding, the coagulation profile 
should be requested and if he is cyanosed, methaemoglobin levels should be assessed. 
Anaemia from haemolysis or bleeding must be corrected with transfusion with red 
cell concentrates. Methaemoglobinaemia is treated with methylene blue (intravenous 
injection of 1-2 mg/kg/dose and repeated if cyanosis persists beyond one hour). However, 
high doses of methylene blue itself can cause haemolysis and it is contraindicated in 
G6PD deficiency. Alternatives to methylene blue in such situations would be hyperbaric 
oxygen and ascorbic acid (a much weaker reducing agent). 
Renal failure must be recognized early by careful monitoring of serum creatinine 
and urine output. Though dialysis is ineffective in clearing copper from the body, it will 
be an essential requirement to sustain life in event of acute kidney injury. Peritoneal 
dialysis is ineffective in maintaining the relatively longer requirement for dialysis until 
the renal functions recover. However, it is an option when haemodialysis facilities are not 
available. 
Chelation therapy in copper sulphate poisoning aims at removing ingested copper 
from the body. The efficacy of these chelating agents is unproven. Penicillamine is a 
commonly used chelating agent at a dose of 1-1.5 g/d in 2-4 divided doses . Both our 
patients received a high dose of oral penicillamine without any ill effects. It must be used 
 carefully in places without access to renal replacement therapy as penicillamine is 
nephrotoxic. Intramuscular administration of dimercaprol or British anti-Lewisite (BAL) 
(3-5 mg/kg/dose with four hourly administration in first two days and tailed off over a 
total of 7-11 days) is recommended when oral administration of penicillamine is difficult 
or contraindicated (severe corrosive injury in alimentary tract). Some authors question its 
efficacy when compared to penicillamine. Edetate Calcium disodium is another option 
and some recommend it as the first line therapy when the use of penicillamine is deemed 
unsafe . There are case reports of patients with copper poisoning being successfully 
treated with edetate calcium disodium followed up by either oral penicillamine or 
dimercaprol. However, edetate calcium disodium also carries the risk of acute tubular 
necrosis and have to be carefully administered with dose reductions in presence of acute 
kidney injury. The duration of chelation therapy is not established by evidence. It is 
recommended to treat with chelators as long as the serum copper level remain above 
normal. 
Despite being rare, intoxication with copper sulphate can be fatal. Therefore it is 
important to concentrate on prevention of copper sulphate ingestion by measures such as;                
1. stopping over the counter sale of copper sulphate and restriction of 
purchase, distribution and sale to authorized agents only 
2.  alternately, over the counter availability of copper sulphate can be limited 
to large sized crystals; cases of poisoning are usually by dissolving the 
fine power like pulverized form of the compound 
responsible for the clinical care of the third patient. All authors have read 
and approved the final manuscript. 
  
 
 
TOXICOLOGICAL 
ASPECT 
 TOXICOLOGICAL ASPECT: 
COPPER SULPHATE (THURUSU) 
Copper sulphate is one of the poisonous compounds of copper. 
The poisonous compounds of copper are 
 Copper sulphate (Blue vitriol, Blue stone) 
 Copper Carbonate 
 Copper subacetate (Verdigris, zangal) 
Mechanism of Action 
 It also acts on sulphydryl group of enzymes 
 It precipitates proteins 
Acute poisoning of copper sulphate 
Signs and symptoms 
 Symptom appear in 15-30 minutes 
 There is a metallic taste, increased salivation 
 Burning pain in the stomach with colicky abdominal pain 
 Thirst, nausea, eructrations and repeated vomiting.  The 
vomited matter is blue or green. 
 There is diarrhoea with much staining; motions are liquid 
and brown but not bloody. 
 Oliguria, haematuria, albuminuria and uraemia may occur. 
 In severe cases haemolysis leads to jaundice and cramps of 
legs or spasms and convulsions occur. 
 The breathing is difficult, cold perspiration and severe 
headache. 
  In some cases paralysis of limbs is followed by drowsiness, 
insensibility, coma and death due to shock. 
 Later death occur due to hepatic or renal failure or both. 
 Exposture of the skin to copper compounds may cause an 
irritant contact dermatitis and severe exposture may cause a 
greenish-blue discolouration of the skin. 
Fatal dose  : 15-30 gms 
Fatal period             : 1-3 days 
Treatment  : 
Antidote: 
a) Physical: Demulcents (forms copper albuminate with proteins) 
b) Chemical: Potassium ferrocyanide (forms insoluble cupric 
ferrocyanide ) 
c) Pharmacological : Pencillamine or BAL or EDTA 
 
 There is no use of emetics (Copper salts are emetics) 
 Gastric lavage-Stomach wash with 1% potassium ferrocyanide, which acts 
as an antidote by forming insoluble cupric ferrocyanide. 
 Demulcent-administration of white of Egg as antidote is advisable.  The 
albumin contained in them will form an insoluble salt, albuminate of 
copper. 
 Caster oil should be given to remove the poison from intestines. 
 Releving pain by injecting morphine hydrochloride hypodermically.  
 Diuretics-Use of diuretics if urine is suppressed is advised. 
  Calcium EDTA by mouth or intravenously as an antidote should be 
carried out. 
 Intra muscular BAL is recommended 
 N pencillamine is very effective. 
 I.V. fluids-The patient should be treated symptomatically to maintain 
electrolyte and fluid balance. 
 Haemodialysis is useful in the early stage of poisoning. 
 For severe cases associated with anorexia and haematuria inj. Cortisone 50 
to 100 mg I.M.  6-8 hourly  or  Prednisolone  10 mg three times a day is 
recommended. 
CHRONIC POISONING OF COPPER SULPHATE: 
 Green or purple line on the gums (at times called Clapton’s line). 
 A metallic taste in the mouth. 
 Nausea, giddiness, headache, dyspepsia, vomitting, diarrhoea with colicky 
pain 
 Laryngitis, bronchitis 
 Nephrotoxicity 
 Anaemia 
 Neuritis, muscle atrophy 
 Body secretions are greenish. 
 Dermatitis. 
ABSORPTION AND EXCRETION 
 Copper is a normal constituent of the body . Copper content of the body is 
150mg. The safe daily intake of dietary copper is 2 to 3mg. 
 It is absorbed through the lungs, mucous membranes and raw surfaces. 
  It is excreted more by the bowels than by the kidney and it traces in saliva, 
bile and milk. 
POST MORTEM APPEARANCE 
 The skin may be yellow. 
 Greenish blue froth at  nose and mouth 
 Oesophagus and stomach congested 
 The contents of the stomach are green or blue and the mucous membrane 
shows superficial and deep erosions and is stained green. 
 Haemmorrhages and ulcerations of intestines 
 The colon sometimes shows large ulceration and the rectum may be 
perforated. 
 In chronic poisoning – degeneration of liver and kidney 
CHEMICAL TEST: 
                  To suspected solution NH4OH- is added, Greenish Blue precipitate confirms 
copper. 
MEDICO LEGAL IMPORTANCE: 
 It is rarely used for homicide because of the colour and taste.  
 Suicidal poisoning is uncommon. 
 Accidental poisoning may occur because Copper salts are used as 
fungicide, as cattle poison, as antidote for phosphorous, to retain green 
colour of vegetables and due to food stored in copper vessels. 
 Children sometimes swallow copper sulphate attracted by its colour. 
 Sometimes, the salts are used as abortifacient and as cattle poison. 
 Copper sulphate is used homicidally mixed with powdered glass, 
sweetmant or some other article of food. 
  Copper sulphate is used in toxicology as : 
a) Emetic agent 
b) Antidote for phosphorous 
 
 
JUR eQ;R FwpFzKk; KwpTk; 
 nrk;gpdpd;W nra;Ak; xU tif cg;Ng JUR vdg;gLk;.  ,J ePhpy; 
fiuaf;$baJ vdNt ,jid cl;nfhz;l cld; FUjpapy; fye;J eQ;rhf;Fk; 
jd;ikAilaJ.  mJ tpiutpy; rhit cz;lhf;Ftjhy; ,jid kf;fs; 
jw;nfhiyf;F mjpfstpy; cgNahfpf;fpd;wdh;.  ,jw;F ePyepwKk;> ntFl;ly; 
RitAk; ,Ug;gjhy; ,jid eQ;R Cl;b gpwiu nfhiy nra;a 
gad;gLj;Jtjpy;iy. 
eQ;R FwpFzk 
 thapy; xU tpj fspk;Gr; RitAz;lhFk; 
 tha; Fkl;ly; fhzg;gLk; 
 thapy; ePUWk;. 
 FUjp fye;j the;jp fhzg;gLk;. 
 ftpr;R ehw;wk; cz;lhf;Fk; 
 tapw;W fLg;Gk;> tapw;wpy; vhpr;rYKz;lhFk;. 
 ePyepwj;Jld; $ba the;jp fhzg;gLk;. 
 njhz;il cyh;jy;> mjpePH Ntl;if>  
 ePuilg;G> fhkhiy> ghrtha;T>  
 grpke;jk;> fz;fspy; ePH tbjy; Nghd;w FwpFzq;fSld; rhit 
tpistpf;Fk;. 
 
  
1.  NjhDe; Jhp Jj;jkpJk; 
 Jyq;fj; jpd;d khdplh;f;F 
 ehZ Klk;G epwk;khwp 
 ed;wha; the;jp ePykNj 
 ePy epwkha; the;jpj;J 
 NeuNu apUf;f ntl;lhky; 
Nfhyq;nfhLf;Fk; Nky; %r;rha; 
Fkl;ly; rw;Wk; jzpahJ 
ghykpl;lhg; NghypUf;Fk; 
ghuf; fgj;jpd; Nfhioajhy; 
Nrhyhawp tPhpf; Fwpia 
nrd;Nw ghHj;J kUe;J}l;Nl 
Cl;Lk; gor;rhW ,Q;rpkJ 
xd;wha;f; fye;Njh ntt;NtNwh 
ehl;L kpjdhy; jPh;e;JtpLk; 
eykh KlYq; Fd;whJ 
$l;bf; fye;jhy; kpfed;W 
Fwpahar; nrhd;Ndh KyNfhHf;F 
G+l;ilj; jpwe;J cs;tpl;Nlhk; 
GtpNahHf; fpjid Gfd;wplhNa 
    -ee;jprh; mfhy kuz E}y; gf;fk; 70 
 Jj;jk; JhpR ,itfisj; jpd;wth;fSf;F clk;G Jtz;L cUtk; khwp 
ePyepwj;jhy; the;jp mjpfkhf vLf;Fk;.  nrk;ikahf ,Uf;f KbahjthW 
rPuopf;Fk; Nky; %r;nrwpAk; tapW Gul;lYk; jzpahJ Njhd;Wk;.  njhlh;njLf;Fk; 
fgj;jpd; jd;ik ghyk; ,l;lhw;Nghy; ,Uf;Fk;.  epiyahd ,j;jifa 
nra;iffsf; fz;L jf;f kUe;J}l;lTk;.  vYkpr;rk; gourj;ijAk; ,Q;rpr; 
 rhiwAk; NjDf;Fg; gjpyhf Kiyg;ghiyAk; cgNahfpf;fyhk;.  NjidAk; 
Nrh;e;Njh my;yJ jdpj;jdpahfNth nfhLj;jhy; FzkhFk; cly; Njwp tUk;.  
fye;J nfhLj;jhy; cj;jkk; if fz;l kUe;jpJ. 
2. Jj;je; JhpR apUtifAk; 
 njhe;jpj; njLj;Jj; jpd;whf;fhy; 
 mbtapw; nte;Js; Gz;zhfp 
 gj;jp naOg;Gk; thilaJ 
 guTk; ghhpy; gyNghf;Fk; 
 rf;jp abf;Fk; apitjPu 
 rhf;fiug; goQ;rhw; (kJ) nfhLj;jpLNk. 
 Jj;jk; JhpR ,uz;ilAk; jpd;why; kyk; fopAk;> top RUq;fp tpLk; 
mbtapW cl;gFjp nte;J uzkhfp nfl;l ehw;wkbj;J gpwiug; gPbf;Fk;.  Rw;wpYk; 
tPRk;.  ,e;j epiyikapy; cs;sth;fSf;F vYkpr;rk; gor;rhw;wpy; rh;f;fiuAk; 
NjidAk; Nrh;j;Jf; nfhLj;jhy; Fzkilth;. 
3.  “J}sh kapy;Jj;jQ; NrhHTlDz; NlhHfl;Fj; 
 jhshd rk;gPur; rhWlNd – Nfsha; eP 
 ,Q;rpePH NjD kpUk;gQ; jhiuAld; 
 nfhe;Jnkhop Az;zf; nfhL” 
 
“Jj;jQ; Ritj;jhHf;Fj; J}ak];J ePuhk;G 
spj;j tte;jpa spf;fyhQ; - Rj;j 
tUzf; fdpr;rhWf; ft;tstpf; Fr;rh 
Wwf;fye; Jz;gpf;f NthLk;” 
                              -eQ;R KwpT  E}y; 
 
 
  
eQ;R KwpT 
 
 JUrpid tplkpf;Fk;gb cz;ltUf;F nghJthd tpjpahf tapw;iwf; 
fOt Ntz;Lk;. 
 the;jpAz;lhf;fp kUe;Jfs; %yk; JUrpid ntspg;gLj;jyhk;.  
,jw;F Kl;il ntz;fU my;yJ ghy; ,tw;iw tapW epiwa 
nfhLf;f Ntz;Lk;. 
 rpWePhpid ngUf;f kUe;J nfhLf;f Ntz;Lk;. 
 vYkpr;rk; gor;rhW 40 kp.yp mstpy; 3 Ntis nfhLf;f Ntz;Lk;. 
 ,Q;rpr;rhW> Njd;> rh;f;fiu ,k;%d;iwAk; Nrh;j;J mUe;jpdhYk; 
JUR eQ;R KwpAk;. 
 japh;ePH my;yJ Gspj;j fhb ePiu  mUe;jpdhYk; JUR eQ;R 
ePf;Fk;. 
 gor;rhw;Wld; fUk;Gr; rhw;iwf; $l;b cz;lhYk; JUR eQ;R ePq;Fk;. 
 
TRICHODESMA INDICUM : 
 
Botanical name: Trichodesma indicum   
 
Family: Boraginaceae  
 
Common name:  
  
 Indian Borage (English) 
 Chhota Kalpa(Hindi)  
 Undhanphuli (Gujarati) 
 Katte tume soppu (Kannada)  
 Kallutaitumapi (Tamil)  
  Guvvagutti (Telugu) 
 Chota Kalpa (Marathi) 
 Adhapuspi (Sanskrit) 
 
This is an erect, spreading, branched, annual herb, about 50 centimeters in height, 
with hairs springing from tubercles. The leaves are stalkless, opposite, lanceolate, 2 to 8 
centimeters long, pointed at the tip, and heart-shaped at the base. The flowers occur 
singly in the axils of the leaves. The sepal tube (calyx) is green, hairy, and 1 to 13 
centimeters long, with pointed lobes. The flower tube is pale blue, with the limb about 
1.5 centimeters in diameter, and the petals pointed. The fruit is ellipsoid, and is enclosed 
by the calyx. The nutlets are about 5 millimeters long, and rough on the inner surface. It 
is found throughout India, on roadsides and stony dry wastelands, upto 1,500 m.  
 
The effect of methanol extract of whole plants of Trichodesma indicum has been 
investigated on sulphur dioxide (SO2) induced cough reflex in Swiss albino mice. The 
extract has demonstrated significant (p < 0.001) inhibition in frequency of cough in all 
the tested doses when compared with untreated control group. The effect persisted up to 
90 min of its oral administration and also comparable to that of the effect exhibited by the 
standard drug (Codeine phosphate). This study confirmed the traditional use of this plant 
in the treatment of cough. Determination of underlying mechanism of beneficial effect is 
major topic requiring further comprehensive investigation. 
 
 
Medicinal Uses: 
 
The plant is acrid, bitter in taste. In herbal medicine jargon, it is thermogenic, 
emollient, alexeteric, anodyne, anti-inflammatory, carminative, constipating, diuretic, 
depurative, ophthalmic, febrifuge and pectoral. This herb is also used in arthralgia, 
inflammations, dyspepsia, diarrhoea, dysentery, strangury, skin diseases and 
dysmenorrhoea. 
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  MATERIALS AND METHODS: 
 
MATERIALS REQUIRED: 
PURIFICATION: 
1. RAW COPPER SULPHATE 
 
2. COW’S URINE(gR%j;jpuk). 
  ,J fhuKk; vwpg;G ehw;wKk; cs;sJ.  fhuKs;sjhy; thA ghpahJ. MfNt 
tapw;wpw;F typitf; nfhLf;Fk;  ,J tapw;Wtyp> mbtapw;Wf;NfhshW> 
ePHf;ftpir> tapw;Wg;gprk; Kjypa Neha;fSf;F cgNahfg;gLk;. 
Drug preparation:  
1. Purified copper sulphate (
2. Leaf extract of Datura metel( ) 
3. Leaf extract of Trichodesma indicum ( ) 
TOXICOLOGICAL STUDY: 
1. Animals   
          Wistar albino rats (200 ± 25 g) bred in the animal house of GSMC, 
palayamkottai, were used. The animals were housed in wire-bottomed cages 
under a uniform condition of temperature and humidity and fed with normal food 
and tap water.  
CHEMICAL ANALYSIS: 
1. AMMONIUM OXALATE 
2. BARIUM CHLORIDE 
3. SILVER NITRATE 
4. CONC. HYDROCHLORIC ACID 
 5. IODINE SOLUTION 
6. GLACIAL ACETIC ACID 
7. POTASSIUM FERRO CYANIDE 
8. CONC. NITRIC ACID 
9. AMMONIUM THIOCYANATE 
10. AMMONIUM MOLYBDATE 
11. ESBATCH‟S REAGENT 
12. FERRIC CHLORIDE 
13. POTASSIUM PERMANGANATE 
14. NINHYDRIN 
15. POTASSIUM FERROCYANIDE 
METHODS: 
PURIFICATION: 
35gm of copper sulphate is taken in a vessel containing cow‟s urine and is heated 
till the cow‟s urine gets dried. This process should be repeated thrice. 
 
 
Figure 3: Purified Thurusu 
  
 
 
 
PREPARATION OF DRUG: 
(REF: ANUBOGA VAITHIYA NAVANEETHAM PART III) 
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Figure 4: Raw Thutusu 
 
 
 
 
Figure 5: Thurusu Parpam 
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 CHEMICAL ANALYSIS: 
 
PREPARATION OF EXTRACT: 
  
        100mgs of the parpam is weighed accurately and placed in a clean beaker and few 
drops of Conc. Hcl is added and allowed to evaporate. Then it is allowed to cool and few 
drops of Conc. Nitric acid is added. It is then allowed to cool and 20ml of distilled water 
is added so that it gets dissolved in it. This is then transferred to 100ml volumetric flask 
and is made up to 100ml with distilled water. This is then mixed, filtered and is taken for 
analysis. 
TEST FOR CALCIUM: 
 2ml of the extract is taken in a clean test tube and 2ml of 4% ammonium oxalate 
solution is added to it. Appearance of white precipitate indicates the presence of calcium. 
TEST FOR SULPHATE: 
 2ml of the extract is added to 5% barium chloride solution. Appearance of white 
precipitate indicates the presence of sulphate. 
TEST FOR CHLORIDE: 
 Extract is treated with silver nitrate solution. Appearance of white precipitate 
indicates the presence of chloride. 
TEST FOR CARBONATE: 
 The substance is treated with concentrated hydrochloric acid. Appearance of brisk 
effervescence indicates the presence of sulphate. 
 
 
 
 TEST FOR STARCH: 
 The extract is added with weak iodine solution. Formation of blue colour 
indicates the presence of starch 
TEST FOR IRON: 
 The extract is acidified with glacial acetic acid and potassium ferrocyanate is 
added. Formation of blood red colour indicates the presence of ferrous iron. 
TEST FOR PHOSPHATE: 
 The extract is treated with ammonium molybdate and concentrated nitric acid. 
Appearance of yellow precipitate indicates the presence of phosphate. 
TEST FOR ALBUMIN: 
 Extract is treated with Esbatch‟s reagent. Formation yellow precipitate indicates 
the presence of albumin. 
TEST FOR TANNIC ACID: 
 The extract is treated with ferric chloride. Appearance of black precipitate 
indicates the presence of tannic acid. 
TEST FOR UNSATURATION: 
 Potassium permanganate is added to the extract. Decolourisation of the solution 
indicates the presence of unsaturated fatty acids 
TEST FOR REDUCING SUGAR: 
 5ml of benedict‟s solution is taken in a test tube and allowed to boil for 2 minutes. 
Then 8-10 drops of extract is added to it and is boiled for 2 minutes. Significant colour 
change indicates the presence of reducing sugar. 
 
 
 
  
TEST FOR AMINO ACID: 
 One or two drops of the extract is placed on a filter paper and dried. After drying 
1% Ninhydrin is sprayed over it and dried. Formation of violet colour indicates the 
presence of amino acid. 
TEST FOR ZINC: 
 The extract is treated with potassium ferro cyanide. Appearance of white 
precipitate indicates the presence of zinc. 
TEST FOR COPPER: 
 Potassium ferrocyanide and acetic acid are added to the above mentioned extract. 
Formation of brown precipitate indicates the presence of copper. 
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 CHEMICAL ANALYSIS 
 
QUALITATIVE ANALYSIS 
 
 
Table 1: chemical analysis of Thurusu Parpam 
 
S.No Substance Result 
1 Calcium + 
2 Sulphate + 
3 Chloride + 
4 Carbonate - 
5 Starch - 
6 Ferric iron - 
7 Ferrous iron - 
8 Phosphate - 
9 Albumin - 
10 Tannic acid - 
11 Unsaturated compounds - 
12 Reducing sugar - 
13 Amino acid - 
14 Zinc - 
15 Copper + 
 
Inference: 
  The extract prepared from the given sample Thurusu parpam contains calcium, 
sulphate, chloride and copper. 
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QUANTITATIVE ANALYSIS: 
Table 2: Physico- Chemical Standardization of Raw Thurusu  
 
S.NO TESTS REPORT 
1 DESCRIPTION BLUE COLOURED CRYSTALS 
2 LOSS ON DRYING AT 105°C 28.58% 
3 TOTAL ASH 59.19% 
4 ACID INSOLUBLE ASH 0.51% 
 
Table 3: Physico- Chemical Standardization of Purified Thurusu  
 
S.NO TESTS REPORT 
1 DESCRIPTION LIGHT GREEN COLOURED POWDER 
2 LOSS ON DRYING AT 105°C 18.19% 
3 TOTAL ASH 54.65% 
4 ACID INSOLUBLE ASH 5.50% 
             
Table 4: Physico- Chemical Standardization of Thurusu Parpam 
 
S.NO TESTS REPORT 
1 DESCRIPTION BLACK COLOURED POWDER 
2 LOSS ON DRYING AT 105°C 0.59% 
3 TOTAL ASH 16.3732% 
4 ACID INSOLUBLE ASH 15.6690% 
 
 
  
FOURIER TRANSFORM INFRA RED SPECTROSCOPY REPORT: 
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                                                                      Figure 1: FTIR of Thurusu 
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  TOXICITY STUDY: 
In order to standardize such medicines it is necessary to evaluate its safety 
and also to find whether it possess toxic properties or not.  So toxicity studies are 
conducted on the animals like mice, albino rats etc. 
 While doing toxicological studies we need the help of following departments. 
 Medicinal botany and Pharmacognosy 
 Pharmacology 
 Biochemistry 
 Histopathology 
 Pharmacy 
 Animal House 
 Bio-statistics 
While doing animal study, there are some criteria and condition to be noted.  They 
are given below. 
SELECTION OF ANIMAL SPECIES 
 Animal experiments are conducted on mice, albino rats, rabbits and dogs.  
Young and immature animals should be selected for the study. 
 While selecting mice, it should be 20-25gm weight and 8-12 weeks of 
growth. 
 In case of albino rats, it should be 80-120gm weight and 12 weeks of 
growth. 
PREPARATION OF ANIMALS 
 Animals should be properly caged and should be fed properly with 
adequate diet. 
  Allow the animals to be in the cage for 5 days before drug administration 
in-order to make them accustomed to the new environment. 
 The temperatue maintained in the animal house should be 19 C - 25 C 
and the humidity should be 30%. 
 Animal house should be 12 hrs dark and the remaining 12 hrs full of light 
 The test animals must be free from infections. 
PREPARATION OF DRUG 
 While doing animal study the dose of the drug given is determined on the 
basis of body weight of the animal. 
 In case of mice and albino rat, the dose of the drug should not exceed 
more than 1 ml for 100gm body weight. 
 When water soluble drugs are given, it must be 2ml/100gm body weight. 
 The adjuvant (anubanam) should be free from toxicity. 
 
PREPARATION OF THE DOSE 
 While doing animal study the dose of the drug given is determined on the 
basis of body weight of the animal. 
 In case of mice and albino rat, the dose of the drug should not exceed 
more than  1 ml for 100gm body weight. 
 When water soluble drugs are given, it must be 2ml/100gm body weight. 
 The adjuvant (anubanam) should be free from toxicity. 
 PROCEDURE 
ADMINISTRATION OF DRUG 
 During drug administration care should be taken that the drug does not 
enter into the respiratory passage.  Before dug administration, the animal 
has to be fasted.  In case of mice and albino rat, the fasting period is 3 hrs 
and 12hrs respectively prior to the study.  The weight of the animal has to 
be noted before drug administration.  Then the drug is administered to the 
animal.  After administration of the drug, the animal should be fed after a 
lapse of 1 to 2 hrs in mice and 3-4 hrs in albino rats. 
NUMBER OF ANIMALS AND DOSE LEVELS 
The dose of the drug given in the animal depends upon 
    1.Body weight of the animal 
    2.Metabolic rate of the animal 
 While conducting acute toxicity study the numbe of animals in each group 
should be four (i.e six groups).  Animals of both sexes should be used.  In 
case of chronic toxicity study the animals are divided into 3 groups, each 
group consisting of 4 animals. 
OBSERVATION 
 In acute toxicity study, the animals are carefully observed during the first 
30 minutes and then observed for 24 hrs.  During that period, the animal 
may show changes in skin, eyes, mucous membrane, blood circulation, 
respiratory movements and the neurological problems may arise. 
 For chronic toxicity study the animals have to be observed for 90 days or 
sometimes up to 1 year.  Some researchers conduct the chronic toxicity 
study for the whole life time of the animal. 
 BODY WEIGHT OF THE ANIMAL 
 The weight of the animal must be taken four times during the course of 
study. 
 First before drug administration 
 After 1 week of drug administration 
 Then 2 weeks after drug administration 
 Finally at the time of sacrificing the animal. 
 
TOXICITY STUDY 
 After sacrificing the animal, the internal organs are sent for 
histopathological studies and recorded. 
DATA AND REPORT 
     At the end of the animal study, the following data‟s must be given. 
 Number of animals selected for the study. 
 Number of animals died due to the toxicity of the drug given. 
 Number of animals sacrificed at the end of animal study. 
 Changes in animal behaviour due to acute and chronic toxicity. 
 Histopathological changes in the internal organs such as liver, kidney and 
heart. 
CHRONIC TOXICITY STUDY 
 This experiment has to be carried out 90 days to one year or one year to five 
years or entire life span of the animal. 
 Observe the animal daily and record the findings observe for cumulative 
effect of toxicity. 
 
  
 
 
 
 
ACUTE 
TOXICITY STUDY 
 
 
 
 TOXICITY STUDY: 
 The toxicity evaluation of THURUSU PARPAM is carried in two phases. 
 Phase I - Acute toxicity study. 
 Phase II - Chronic toxicity study. 
ACUTE TOXICITY STUDY: 
Animals 
 Wistar albino rats bred in the animal house attached to the post graduate, 
pharmacology Department, Government Siddha Medical College, 
Palayamkottai were used. 
Sex 
 Animals of both sex were used. 
Weight 
 Animals weighing between 80-120 gms were selected. 
Food and water 
 The animals were maintained with standard animal feed and water ad-
libitum.  
Number of Animals 
 24 Albino rats divided into 6 groups each group consisting of 4 rats. 
Dose Levels 
 The following dose levels were fixed by persuming range of least toxic to 
high toxic doses. 
I Group - Control 
II Group - 40 mg/100 gm body weight of the animal. 
III Group - 80 mg/100 gm body weight of the animal. 
IV Group - 160 mg/100 gm body weight of the animal. 
  
V Group - 320 mg/100 gm body weight of the animal. 
VI Group - 640 mg/100 gm body weight of the animal. 
Route of administration 
 The drug was administered orally. 
Drug preparation 
 The drug was weighed and taken and suspended in Honey, which is heated 
& melted, as a suspending agent.  The mixture was ground well before the 
administration.  The preparation was done in such a way that 1ml of 
suspension contains dose ranging from 40mg to 640 mg of THURUSU 
PARPAM which is given to the respective groups, as classified above in 
the doses level.  The drug was administrated  in morning and observed. 
Observation 
 The following details were recorded 
CENTRAL EFFECTS: 
I.Stimulation 
 Hyperactivity 
 Pyloerection 
 Twitching 
 Rigidity 
 Irritability 
 Jumping 
 Clonic convulsions 
 Tonic convulsions 
 
  
II.Depression 
 Ptosis 
 Sedation 
 Sleep 
 Loss of traction 
 Loss of pinna reflex 
 Ataxia 
 Loss of muscle tone 
 Analgesia 
 AUTONOMIC EFFECTS: 
 Straub tail 
 Laboured respiration 
 Cyanosis 
 Blanching 
 Reddening 
 Abnormal secretions 
At the end of 24 hours the number of animals live or dead in each group was 
noted and the approximate LD 50 was detetrmined.  The animal were 
morphologically examined for any toxic symptoms. 
 Tables which show the result of Acute toxicity study of  THURUSU 
PARPAM as follows: 
 Table 2: Acute Toxicity Study of THURUSU PARPAM on control 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic 
convulsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic effect: 
Straub tail 
Laboured Respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
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- 
- 
- 
- 
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- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
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- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
 Table 3: Acute Toxicity Study of THURUSU PARPAM  on group II (40mg/100g 
body weight) 
 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic convulsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic effect: 
Straub tail 
Laboured respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
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- 
 
 
- 
- 
- 
- 
- 
- 
- 
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- 
- 
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- 
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- 
- 
- 
- 
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- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
                             
 Table 4: Acute Toxicity Study of THURUSU PARPAM on Group III (80mg/100g 
body weight) 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic convlsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic 
effect: 
Straub tail 
Laboured respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
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- 
- 
- 
- 
- 
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- 
- 
- 
- 
- 
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- 
- 
- 
- 
- 
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- 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
                                                  
 Table 5: Acute Toxicity Study of THURUSU PARPAM on group IV (160mg/ 100g 
body weight) 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic convulsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic effect: 
Straub tail 
Laboured respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
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- 
 
 
- 
- 
- 
- 
- 
- 
- 
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- 
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- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
 Table 6: Acute Toxicity Study of THURUSU PARPAM on group V (320mg/100g 
body weight) 
 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic convulsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic effect: 
Straub tail 
Laboured respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
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- 
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- 
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- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
 Table 7: Acute Toxicity Study of THURUSU PARPAM on group VI (640mg/ 100g 
body weight) 
 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.Stimulation: 
Hyperactivity 
Pyloerection 
Twitching 
Rigidity 
Irritability 
Jumping 
Clonic convulsions 
Tonic convulsions 
II.Depression: 
Ptosis 
Sedation 
Sleep 
Loss of traction 
Loss of pinna reflex 
Ataxia 
Loss of muscle tone 
Analgesia 
III. Autonomic effect: 
Straub tail 
Laboured respiration 
Cyanosis 
Blanching 
Reddening 
Abnormal Secretions 
IV.Number of dead 
after 24 hrs: 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
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- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
 
  --Negative           + Positive 
                                                  
 RESULT 
Acute Toxicity Study 
The said parameters in acute toxicity study were observed on six groups (Group I, 
II, III, IV, V, VI). Group II, III, IV, V, VI were administrated with drugs such as 40mg, 
80mg, 160mg, 320mg, 640mg /100 gm body weight of the animal respectively. 
The results were tabulated in the table 1 to 6.  From the table 2 to 6 it being found 
that the drug THURUSU PARPAM did not produce any mortality even upto 640mg /100 
gm body weight of the animal. 
Table 8: Acute Toxicity Study Analysis 
 
Group Dose in mg/100gm body  
weight of animal 
      No of rats    No of rats  
died 
II 40 4 - 
III 80 4 - 
IV 160 4 - 
V 320 4 - 
VI 640 4 - 
 
  
Median Lethal Dose (LD 50): 
 It is the dose which kills half the population of the animal tested. 
 Since it is practically difficult to administrate more than 640mg/100gm body 
weight of the animal (Wistar albino rat) and there is no mortality of animals taken for the 
study it is unable to calculate the lethal dose in this preliminary acute toxicity study. So it 
is inferred that the drug is found to be safe upto 640mg/100gm body weight of the 
animal. 
  
 
 
CHRONIC 
TOXICITY STUDY 
 CHRONIC TOXICITY STUDY: 
Introduction 
  THURUSU PARPAM is used for the treatment of Asta Gunmam & Iraippu Noi,  
etc., in siddha system of medicine. 
Since this drug is usually used on a long term basis for chronic ailments, it was 
decided to find the chronic toxic potentiality of the THURUSU PARPAM in 
experimental animals called Wistal albino rats. 
Animals 
Wistar albino rats bred in the animal house attached to the post graduate, 
Pharmacology Department, Government Siddha Medical College, Palayamkottai were 
used. 
Sex 
Animals of both sexes were used. 
Weight 
Animals weighing between 80-120 gms. 
Food and water 
The animals were maintained with standard animal feed and water ad-libitum. 
Number of Animals 
12 Albino rats are divided into 3 groups each group consisting of 4 rats. 
Selection of dose level 
Two doses were selected from the acute toxicity study.  These doses did not have 
any acute toxicity effect and presumed to be safe for long term administration in animals. 
I Group  - Control 
II Grou p  - 40mg / 100 gm body weight of the animal. 
III Group  - 80mg / 100 gm body weight of the animal. 
 Route of administration 
 The drug was administered orally for about 3 months. 
Drug preparation 
 The drug was weighted and taken and suspended in Honey, the mixture 
was ground well before the administration.  The preparation was done in 
such a way that 1 ml of suspension contains dose ranging from 40 mg/ml 
and 80mg/ml of THURUSU PARPAM for the groups taken.  The 
prepared drug was administrated once a day (morning) for 90 days. 
Observation 
The following details were recorded before and after the drug administration. 
1. Body weight of the animal 
2. Haematological investigations 
a) W.B.C Total count 
b) W.B.C Differential count 
c) Haemoglobin 
Every month and at the end of the experiment, the above parameters were 
recorded and the results were tabulated. 
One animal from each group, were sacrificed at the end of the  experiment and 
were dissected.  The visceras like Liver, Kidney and Heart were removed from each 
animal and was preserved in 40% formalin solution send for Histo-pathological studies. 
Histopathological procedure 
The sections were stained with haemotoxillin and eosin and the histopathological 
report was given by Dr.K.Swaminathan, Professor of Pathology Department, Tirunelveli 
Medical College. 
 The tabular column shown in tested parameters and changes in histopathological 
specimens were also documented. 
   
Table 9: Chronic Toxicity Study Analysis 
 
Group Dose (mg/100gm) No of rats Days 
No of rats 
died 
I 40 4 
0 - 
30 - 
90 - 
II 80 4 
0 - 
30 - 
90 - 
 
HAEMATOLOGICAL AND WEIGHT CHANGES: 
The details of the changes in weight and haematology are given in the following table: 
 
Table 10: Hematological report on Group I 
 
S.No Blood 
At O‟ day 
(Mean) 
At 30
th
 day 
(Mean) 
At 90
th
 day 
(Mean) 
1 WBC Total count 8900/cumm 9100/cumm 9200/cumm 
2 
Differential Count 
Neutrophil 28% 26% 24% 
Eosionophil - - - 
Basophil - - - 
Lymphocyte 72% 74% 76% 
Monocyte - - - 
3. Haemoglobin % 66 68 70 
4. Body Weight 100 gm 102 gm 104 gm 
   
 Table 11: Hematological report on Group II 
 
S.No Blood 
At O‟ day 
(Mean) 
At 30
th
 day 
(Mean) 
At 90
th
 day 
(Mean) 
1 WBC Total count 9500/cumm 9700/cumm 9800/cumm 
2 
Differential Count 
Neutrophil 32% 28% 24% 
Eosionophil - - - 
Basophil - - - 
Lymphocyte 68% 72% 76% 
Monocyte - - - 
3. Haemoglobin % 68 70 72 
4. Body Weight 100 gm 105 gm 110 gm 
   
 
 
 
 
Table 12: Hematological report on Group III 
 
S.No Blood 
At O‟ day 
(Mean) 
At 30
th
 day 
(Mean) 
At 90
th
 day 
(Mean) 
1 WBC Total count 9200/cumm 9400/cumm 9600/cumm 
2 
Differential Count 
Neutrophil 30% 26% 20% 
Eosionophil - 2 2 
Basophil - - - 
Lymphocyte 70% 72% 78% 
Monocyte - - - 
3. Haemoglobin % 66 68 70 
4. Body Weight 100 gm 110 gm 120 gm 
   
  
HISTO-PATHOLOGY STUDY 
HISTO-PATHOLOGY OF LIVER OF RAT: 
  
 
  
 
  
 
Low Dose (40mg) Exposure: 
Section studied shows liver tissue 
with mild sinusoidal dilatation with 
focal congestion. 
High Dose (80mg) Exposure: 
Section studied shows liver tissue 
with focal necrosis and  mild 
sinusoidal dilatation 
Control: Section studied shows 
normal liver tissue 
 
 HISTO-PATHOLOGY OF KIDNEY OF RAT: 
 
  
 
  
 
  
 
Low Dose (40mg) Exposure: 
Section studied shows normal 
glomeruli with focal interstitial 
edema.  
High Dose (80mg)Exposure: 
Section studied shows normal 
glomeruli with focal interstitial 
edema with inflammatory cell 
infiltration 
 
Control: Section studied shows 
normal kidney tissue 
 
  
HISTO-PATHOLOGY OF HEART OF RAT: 
 
  
 
  
 
  
                        
 
 
Low Dose (40mg) Exposure: 
Section studied shows normal 
bundles of myocardial fibers. 
High Dose (80mg) Exposure: 
Section studied shows normal 
bundles of myocardial fibers. 
 
Control: Section studied shows 
normal heart tissue 
 
 HISTOPATHOLOGICAL CHANGES ON WISTER ALBINO RATS 
CHRONIC TOXICITY  STUDY 
 
GroupI – Control 
Liver:    Section from the Liver shows normal Lobular architecture 
Kidney: Section from the kidney shows normal Glomeruli with normal tubles 
Heart:    Section from the heart shows Myocardium with normal histomorphology 
  
Group II     
 
    The effect of THURUSU PARPAM at the dose of 40mg/100gm body weight of  the 
animal. 
Liver : Section studied shows liver tissue with mild sinusoidal dilatation with focal 
congestion. 
Kidney : Section studied shows normal glomeruli with focal interstitial edema 
Heart : Section studied shows normal bundles of myocardial fibers. 
 
 
Group III 
  
    The effect of THURUSU PARPAM at the dose of 80mg/100gm body weight of  the 
animal 
Liver : Section studied shows liver tissue with focal necrosis and  mild sinusoidal 
dilatation  
Kidney : Section studied shows normal glomeruli with focal interstitial edema with 
inflammatory cell infiltration 
Heart : Section studied shows normal bundles of myocardial fibers.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 DISCUSSION: 
 
The chemical analysis showed the presence of calcium, chloride, sulphate and 
copper. The therapeutic dose of Thurusu Parpam is usually 65mg/dose with 
consumption of three times a day. That shows if a person consumes Thurusu Parpam 
under these regulations, total intake in a week will be 1.2mg.  
 But ingestion of 10 times the therapeutic dose in acute study doesn‟t show any 
notable toxic symptoms in animals. This contrary result in animal study may be due to 
the fact that the drug is administered along with honey as adjuvant, which may play an 
important role in reducing its toxic properties. Moreover, the permissible limits 
regulations by WHO applies mainly to long term exposure to copper for months. But 
usually the drug is given only for a week.  
 In case of humans, some factors such as food habits may also play an important 
role in determining the toxicity of copper-containing drugs. Because most of the toxicity 
work done by WHO is on western population, which follows very different food habits 
compared with a normal Indian population. For example, intake of common food 
ingredients such as sesame oil, turmeric, tamarind, garlic, and asafoetida may play an 
important role in prevention of toxic effects of copper. This becomes more evident from 
the south Indian population which consumes sea food in large amount.  
 In chronic studies, after the administration of drug of more than  30days, 
Histo-pathology of kidney showed normal glomeruli with focal interstitial edema with 
inflammatory cells infiltration. But this may be reversible, as it didn‟t produce any 
significant toxic symptom in animals. Another unexplored facet, which could affect the 
efficacy and toxicity of these drugs, are drug-drug interaction that occurs when they are 
given in combination with other herbal preparations. . Although Thurusu Parpam have 
 metal contents far greater than the WHO limits, the toxicity of a preparation need not 
directly correlate with the metal content in the sample. The chemical nature of the metal, 
route of administration, dosage, residence time within the body, pharmacokinetics and 
dynamics, bioavailability, metabolic transformations of the preparation, age, gender, 
physiology, nature and stage of disease, and diet can influence the toxic manifestations of 
the drug. Hence a detailed study on all these factors is essential to answer the 
comprehensions raised by the usage of herbo-metallic drugs like Thurusu Parpam. 
 Another unexplored facet, which could affect the efficacy and toxicity of these 
drugs, are drug-drug interaction that occurs when they are given in combination with 
other herbal preparations. The fact that mercury sulfide is insoluble and does not get 
absorbed through blood circulation eliminates its chances of providing therapeutic 
benefits, since it may not react at all with the cell receptors. However, incorporation of 
herbal ingredients in these preparations may alter the cell uptake, distribution, and 
elimination profile as well as the therapeutic properties. So a detailed study on all these 
factors is necessary. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY: 
  
           Toxicological effect of Thurusu Parpam, a known drug used in treatment 
Respiratory and G-I tract disorders is evaluated in this research work. Various 
quantitative and qualitative analysis has shown the presence of sulphate, calcium and 
chloride and copper in the drug. An acute and chronic study was performed in wister 
albino rats for a period of 24hours and 90days respectively. 
 In acute study, all the animals fed with the drug doesn‟t showed any toxicological 
symptoms with normal hematological reports But in case of chronic toxicity studies, 
though animals didn‟t show any toxic symptoms at higher dosage levels (80mg/100gm), 
histopathology studies revealed the presence of focal interstitial edema with 
inflammatory cell infiltration in kidney and focal necrosis and mild sinusoidal dilatation 
in liver. These data‟s indicate that though the drug is toxic at higher levels, but very safe 
at therapeutic dosage prescribed by siddha medical practitioners. 
So over consumption due to improper medication/self-medication may lead to 
significant toxic effects. Although most of the siddha medicinal preparations have metal 
contents far greater than the WHO limits, the toxicity of a preparation need not directly 
correlate with the metal content in the sample. The chemical nature of the metal, route of 
administration, dosage, residence time within the body, pharmacokinetics and dynamics, 
bioavailability, metabolic transformations of the preparation, age, gender, physiology, 
nature and stage of disease, and diet can influence the toxic manifestations of the Thurusu 
Parpam. Therefore, a careful analysis of all these parameters is required in order to 
establish the risk involved in Thurusu Parpam. 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 CONCLUSION: 
 
  
           Even though the metals are purified and believed to be non-toxic according to 
Siddha system, this only refers to the clinical or therapeutic dose, which is minimal. So 
over consumption due to improper medication/self-medication may lead to significant 
toxic effects. Although most of the siddha medicinal preparations have metal contents far 
greater than the WHO limits, the toxicity of a preparation need not directly correlate with 
the metal content in the sample. The chemical nature of the metal, route of 
administration, dosage, residence time within the body, pharmacokinetics and dynamics, 
bioavailability, metabolic transformations of the preparation, age, gender, physiology, 
nature and stage of disease, and diet can influence the toxic manifestations of the 
Thurusu Parpam. Therefore, a careful analysis of all these parameters is required in 
order to establish the risk involved in a given Thurusu Parpam. Variations in therapeutic 
doses are recommended by practitioners for different ailments. Practioners in siddha 
medicines adopt a holistic approach to treatment and consider the physiological aspects 
of an individual along with the type of disease and stage of presentation. Diet restrictions 
also contribute to alterations in the pharmacokinetics, and thus labeling a traditional 
medicine preparation as toxicity based only on the metal content seems inappropriate. 
However, in-depth and systematic investigations are not available for these preparations. 
Pre-clinical studies are needed after conversion of the human therapeutic dose to an 
animal dose, and both short-term and long-term toxicity have to be evaluated. 
Significant and substantial amount of data through these studies can provide a 
platform for designing human clinical trials. Even though cinnabar has been used for 
centuries in traditional medicine, pharmaco-vigilance never existed then and does not 
 even prevail in the modern era. The need for patient follow-up after counseling and drug 
therapy was rare in earlier times, and even now it is not followed stringently. Hence, 
scientific evidence is lacking to confirm the safety and efficacy of these drugs. No 
pharmco-therapeutic studies exist to analyze the benefits of these drugs. Shortcomings in 
choice of animal models and proper design of experiments to assess toxicity have 
hampered the risk assessment of these traditional preparations, and hence there is a 
requirement for more comprehensive studies to understand the ramifications of these 
therapeutic processes. 
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